Publications: Jennifer Doudna
Download CSV for Jennifer Doudna
| Title | Year | Citations | Score |
|---|---|---|---|
|
A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity
science 337 (6096), 816-821, 2012 View on Google Scholar ↗ |
2012 | 25543 | 100.0% |
|
The new frontier of genome engineering with CRISPR-Cas9
Science 346 (6213), 1258096, 2014 View on Google Scholar ↗ |
2014 | 10640 | 99.9% |
|
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression
Cell 152 (5), 1173-1183, 2013 View on Google Scholar ↗ |
2013 | 7215 | 99.9% |
|
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Science 360 (6387), 436-439, 2018 View on Google Scholar ↗ |
2018 | 5355 | 99.9% |
|
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes
Cell 154 (2), 442-451, 2013 View on Google Scholar ↗ |
2013 | 5351 | 99.8% |
|
CRISPR technology: A decade of genome editing is only the beginning
Science 379 (6629), eadd8643, 2023 View on Google Scholar ↗ |
2023 | 1360 | 99.8% |
|
CRISPR/Cas, the immune system of bacteria and archaea
Science 327 (5962), 167-170, 2010 View on Google Scholar ↗ |
2010 | 3826 | 99.7% |
|
RNA-programmed genome editing in human cells
elife 2, e00471, 2013 View on Google Scholar ↗ |
2013 | 3295 | 99.7% |
|
CRISPR–Cas9 structures and mechanisms
Annual review of biophysics 46, 505-529, 2017 View on Google Scholar ↗ |
2017 | 3092 | 99.7% |
|
Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy
Cell 184 (2), 323-333. e9, 2021 View on Google Scholar ↗ |
2021 | 1171 | 99.6% |
|
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Nature 507 (7490), 62-67, 2014 View on Google Scholar ↗ |
2014 | 2805 | 99.6% |
|
RNA-guided genetic silencing systems in bacteria and archaea
Nature 482 (7385), 331-338, 2012 View on Google Scholar ↗ |
2012 | 3054 | 99.6% |
|
The promise and challenge of therapeutic genome editing
Nature 578 (7794), 229-236, 2020 View on Google Scholar ↗ |
2020 | 1405 | 99.5% |
|
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Nature biotechnology 38 (7), 883-891, 2020 View on Google Scholar ↗ |
2020 | 1330 | 99.5% |
|
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Nature biotechnology 31 (9), 839-843, 2013 View on Google Scholar ↗ |
2013 | 2152 | 99.4% |
|
CRISPR-Cas guides the future of genetic engineering
Science 361 (6405), 866-869, 2018 View on Google Scholar ↗ |
2018 | 1779 | 99.4% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent 10,266,850, 2019 View on Google Scholar ↗ |
2019 | 1174 | 99.3% |
|
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Science 343 (6176), 1247997, 2014 View on Google Scholar ↗ |
2014 | 1930 | 99.3% |
|
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
Science 362 (6416), 839-842, 2018 View on Google Scholar ↗ |
2018 | 1486 | 99.3% |
|
In vivo human T cell engineering with enveloped delivery vehicles
Nature Biotechnology 42 (11), 1684-1692, 2024 View on Google Scholar ↗ |
2024 | 307 | 99.2% |
|
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
Nature 550 (7676), 407-410, 2017 View on Google Scholar ↗ |
2017 | 1515 | 99.2% |
|
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
elife 3, e04766, 2014 View on Google Scholar ↗ |
2014 | 1676 | 99.2% |
|
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
Nature 538 (7624), 270-273, 2016 View on Google Scholar ↗ |
2016 | 1571 | 99.2% |
|
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein
Nature biotechnology 43 (9), 1445-1457, 2025 View on Google Scholar ↗ |
2025 | 221 | 99.1% |
|
Applications of CRISPR technologies in research and beyond
Nature biotechnology 34 (9), 933-941, 2016 View on Google Scholar ↗ |
2016 | 1468 | 99.1% |
|
Molecular mechanisms of RNA interference
Annual review of biophysics 42, 217-239, 2013 View on Google Scholar ↗ |
2013 | 1565 | 99.1% |
|
Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering
Cell 164 (1), 29-44, 2016 View on Google Scholar ↗ |
2016 | 1369 | 99.1% |
|
Species-and site-specific genome editing in complex bacterial communities
Nature microbiology 7 (1), 34-47, 2022 View on Google Scholar ↗ |
2022 | 374 | 99.0% |
|
CRISPR-CasΦ from huge phages is a hypercompact genome editor
Science 369 (6501), 333-337, 2020 View on Google Scholar ↗ |
2020 | 727 | 98.9% |
|
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Cell 186 (21), 4567-4582. e20, 2023 View on Google Scholar ↗ |
2023 | 252 | 98.9% |
|
Crystal structure of a group I ribozyme domain: principles of RNA packing
Science 273 (5282), 1678-1685, 1996 View on Google Scholar ↗ |
1996 | 1779 | 98.8% |
|
Clades of huge phages from across Earth’s ecosystems
Nature 578 (7795), 425-431, 2020 View on Google Scholar ↗ |
2020 | 632 | 98.7% |
|
A prudent path forward for genomic engineering and germline gene modification
Science 348 (6230), 36-38, 2015 View on Google Scholar ↗ |
2015 | 1080 | 98.7% |
|
An updated evolutionary classification of CRISPR–Cas systems including rare variants
Nature microbiology 10 (12), 3346-3361, 2025 View on Google Scholar ↗ |
2025 | 149 | 98.7% |
|
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Nature biomedical engineering 1 (11), 889-901, 2017 View on Google Scholar ↗ |
2017 | 941 | 98.6% |
|
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Proceedings of the National Academy of Sciences 112 (33), 10437-10442, 2015 View on Google Scholar ↗ |
2015 | 973 | 98.5% |
|
Structural basis for double-stranded RNA processing by Dicer
Science 311 (5758), 195-198, 2006 View on Google Scholar ↗ |
2006 | 1423 | 98.5% |
|
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
Science 374 (6575), 1626-1632, 2021 View on Google Scholar ↗ |
2021 | 385 | 98.4% |
|
Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage
Science 351 (6275), 867-871, 2016 View on Google Scholar ↗ |
2016 | 921 | 98.4% |
|
Sequence-and structure-specific RNA processing by a CRISPR endonuclease
Science 329 (5997), 1355-1358, 2010 View on Google Scholar ↗ |
2010 | 1194 | 98.4% |
|
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Nature 607 (7918), 351-355, 2022 View on Google Scholar ↗ |
2022 | 243 | 98.3% |
|
Structural biology of CRISPR–Cas immunity and genome editing enzymes
Nature Reviews Microbiology 20 (11), 641-656, 2022 View on Google Scholar ↗ |
2022 | 240 | 98.3% |
|
Birth of protein folds and functions in the virome
Nature 633 (8030), 710-717, 2024 View on Google Scholar ↗ |
2024 | 149 | 98.3% |
|
Programmable RNA recognition and cleavage by CRISPR/Cas9
Nature 516 (7530), 263-266, 2014 View on Google Scholar ↗ |
2014 | 879 | 98.3% |
|
CasX enzymes comprise a distinct family of RNA-guided genome editors
Nature 566 (7743), 218-223, 2019 View on Google Scholar ↗ |
2019 | 581 | 98.2% |
|
New CRISPR–Cas systems from uncultivated microbes
Nature 542 (7640), 237-241, 2017 View on Google Scholar ↗ |
2017 | 812 | 98.2% |
|
Conformational control of DNA target cleavage by CRISPR–Cas9
Nature 527 (7576), 110-113, 2015 View on Google Scholar ↗ |
2015 | 831 | 98.2% |
|
A three-dimensional view of the molecular machinery of RNA interference
nature 457 (7228), 405-412, 2009 View on Google Scholar ↗ |
2009 | 1103 | 98.2% |
|
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
Proceedings of the National Academy of Sciences 119 (31), e2200592119, 2022 View on Google Scholar ↗ |
2022 | 220 | 98.1% |
|
A Cas9–guide RNA complex preorganized for target DNA recognition
Science 348 (6242), 1477-1481, 2015 View on Google Scholar ↗ |
2015 | 787 | 98.1% |
|
Accelerated RNA detection using tandem CRISPR nucleases
Nature chemical biology 17 (9), 982-988, 2021 View on Google Scholar ↗ |
2021 | 307 | 97.9% |
|
Viral delivery of an RNA-guided genome editor for transgene-free germline editing in Arabidopsis
Nature Plants 11 (5), 967-976, 2025 View on Google Scholar ↗ |
2025 | 106 | 97.8% |
|
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Cell 185 (9), 1539-1548. e5, 2022 View on Google Scholar ↗ |
2022 | 189 | 97.7% |
|
Programmable RNA tracking in live cells with CRISPR/Cas9
Cell 165 (2), 488-496, 2016 View on Google Scholar ↗ |
2016 | 672 | 97.6% |
|
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Cell 186 (21), 4597-4614. e26, 2023 View on Google Scholar ↗ |
2023 | 130 | 97.6% |
|
In vivo site-specific engineering to reprogram T cells
Nature 652 (8110), 712-721, 2026 View on Google Scholar ↗ |
2026 | 63 | 97.6% |
|
Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity
Nature structural & molecular biology 21 (6), 528-534, 2014 View on Google Scholar ↗ |
2014 | 695 | 97.6% |
|
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Cell 187 (25), 7143-7163. e22, 2024 View on Google Scholar ↗ |
2024 | 104 | 97.5% |
|
Targeted nonviral delivery of genome editors in vivo
Proceedings of the National Academy of Sciences 121 (11), e2307796121, 2024 View on Google Scholar ↗ |
2024 | 103 | 97.5% |
|
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Cell reports 35 (9), 2021 View on Google Scholar ↗ |
2021 | 261 | 97.5% |
|
Structural basis for CRISPR RNA-guided DNA recognition by Cascade
Nature structural & molecular biology 18 (5), 529-536, 2011 View on Google Scholar ↗ |
2011 | 821 | 97.4% |
|
Rapid detection of SARS-CoV-2 RNA in saliva via Cas13
Nature biomedical engineering 6 (8), 944-956, 2022 View on Google Scholar ↗ |
2022 | 171 | 97.4% |
|
A crack in creation: The new power to control evolution
Random House, 2017 View on Google Scholar ↗ |
2017 | 590 | 97.4% |
|
Genome-resolved metagenomics reveals site-specific diversity of episymbiotic CPR bacteria and DPANN archaea in groundwater ecosystems
Nature microbiology 6 (3), 354-365, 2021 View on Google Scholar ↗ |
2021 | 253 | 97.4% |
|
Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors
Cell 185 (24), 4574-4586. e16, 2022 View on Google Scholar ↗ |
2022 | 167 | 97.4% |
|
Crystal structure of a hepatitis delta virus ribozyme
Nature 395 (6702), 567-574, 1998 View on Google Scholar ↗ |
1998 | 1069 | 97.3% |
|
Cornerstones of CRISPR–Cas in drug discovery and therapy
Nature reviews Drug discovery 16 (2), 89-100, 2017 View on Google Scholar ↗ |
2017 | 583 | 97.3% |
|
The chemical repertoire of natural ribozymes
Nature 418 (6894), 222-228, 2002 View on Google Scholar ↗ |
2002 | 1129 | 97.3% |
|
RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions
Proceedings of the National Academy of Sciences 108 (25), 10092-10097, 2011 View on Google Scholar ↗ |
2011 | 783 | 97.3% |
|
Insights into RNA structure and function from genome-wide studies
Nature Reviews Genetics 15 (7), 469-479, 2014 View on Google Scholar ↗ |
2014 | 626 | 97.3% |
|
Controlling and enhancing CRISPR systems
Nature chemical biology 17 (1), 10-19, 2021 View on Google Scholar ↗ |
2021 | 242 | 97.2% |
|
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
Cell 187 (25), 7248-7266. e34, 2024 View on Google Scholar ↗ |
2024 | 93 | 97.2% |
|
Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9
Cell 187 (13), 3249-3261. e14, 2024 View on Google Scholar ↗ |
2024 | 90 | 97.1% |
|
Expanding the biologist’s toolkit with CRISPR-Cas9
Molecular cell 58 (4), 568-574, 2015 View on Google Scholar ↗ |
2015 | 565 | 97.0% |
|
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
Nature microbiology 7 (12), 1967-1979, 2022 View on Google Scholar ↗ |
2022 | 147 | 96.9% |
|
Single-molecule live-cell RNA imaging with CRISPR–Csm
Nature biotechnology 43 (12), 2023-2030, 2025 View on Google Scholar ↗ |
2025 | 80 | 96.9% |
|
A roadmap for affordable genetic medicines
Nature 634 (8033), 307-314, 2024 View on Google Scholar ↗ |
2024 | 84 | 96.8% |
|
Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases
Science 385 (6708), 538-543, 2024 View on Google Scholar ↗ |
2024 | 80 | 96.6% |
|
Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity
Nature 519 (7542), 193-198, 2015 View on Google Scholar ↗ |
2015 | 515 | 96.6% |
|
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
Nature biotechnology 35 (5), 431-434, 2017 View on Google Scholar ↗ |
2017 | 472 | 96.6% |
|
Structures of the RNA-guided surveillance complex from a bacterial immune system
Nature 477 (7365), 486-489, 2011 View on Google Scholar ↗ |
2011 | 651 | 96.5% |
|
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation
Nature 536 (7614), 96-99, 2016 View on Google Scholar ↗ |
2016 | 475 | 96.5% |
|
Precise transcript targeting by CRISPR-Csm complexes
Nature biotechnology 41 (9), 1256-1264, 2023 View on Google Scholar ↗ |
2023 | 90 | 96.4% |
|
Disabling Cas9 by an anti-CRISPR DNA mimic
Science advances 3 (7), e1701620, 2017 View on Google Scholar ↗ |
2017 | 444 | 96.3% |
|
CRISPR–Cas9 bends and twists DNA to read its sequence
Nature structural & molecular biology 29 (4), 395-402, 2022 View on Google Scholar ↗ |
2022 | 126 | 96.3% |
|
Genome integrity sensing by the broad-spectrum Hachiman antiphage defense complex
Cell 187 (24), 6914-6928. e20, 2024 View on Google Scholar ↗ |
2024 | 72 | 96.2% |
|
Dynamics of CRISPR-Cas9 genome interrogation in living cells
Science 350 (6262), 823-826, 2015 View on Google Scholar ↗ |
2015 | 469 | 96.2% |
|
Improved genome editing by an engineered CRISPR-Cas12a
Nucleic acids research 50 (22), 12689-12701, 2022 View on Google Scholar ↗ |
2022 | 121 | 96.1% |
|
In vitro reconstitution of the human RISC-loading complex
Proceedings of the National Academy of Sciences 105 (2), 512-517, 2008 View on Google Scholar ↗ |
2008 | 668 | 96.1% |
|
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
Nature Biotechnology 39 (1), 84-93, 2021 View on Google Scholar ↗ |
2021 | 185 | 96.1% |
|
DNA capture by a CRISPR-Cas9–guided adenine base editor
Science 369 (6503), 566-571, 2020 View on Google Scholar ↗ |
2020 | 257 | 96.0% |
|
Engineering self-deliverable ribonucleoproteins for genome editing in the brain
nature communications 15 (1), 1727, 2024 View on Google Scholar ↗ |
2024 | 68 | 96.0% |
|
CRISPR technology: A decade of genome editing is only the beginning. Science 379, eadd8643
2023 View on Google Scholar ↗ |
2023 | 80 | 95.9% |
|
Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity
Cell reports 3 (5), 1362-1368, 2013 View on Google Scholar ↗ |
2013 | 489 | 95.8% |
|
RNA targeting by functionally orthogonal type VI-A CRISPR-Cas enzymes
Molecular cell 66 (3), 373-383. e3, 2017 View on Google Scholar ↗ |
2017 | 394 | 95.7% |
|
Rational design of a split-Cas9 enzyme complex
Proceedings of the National Academy of Sciences 112 (10), 2984-2989, 2015 View on Google Scholar ↗ |
2015 | 422 | 95.6% |
|
Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation
Molecular cell 35 (6), 868-880, 2009 View on Google Scholar ↗ |
2009 | 572 | 95.6% |
|
Tunable protein synthesis by transcript isoforms in human cells
elife 5, e10921, 2016 View on Google Scholar ↗ |
2016 | 379 | 95.3% |
|
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
Science advances 3 (8), eaao0027, 2017 View on Google Scholar ↗ |
2017 | 357 | 95.2% |
|
The NIH somatic cell genome editing program
Nature 592 (7853), 195-204, 2021 View on Google Scholar ↗ |
2021 | 157 | 95.2% |
|
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA. 1 variant through NSP6
Nature Communications 14 (1), 2308, 2023 View on Google Scholar ↗ |
2023 | 70 | 95.2% |
|
Multiplexed RNA structure characterization with selective 2′-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq)
Proceedings of the National Academy of Sciences 108 (27), 11063-11068, 2011 View on Google Scholar ↗ |
2011 | 504 | 95.2% |
|
CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing
Nature communications 8 (1), 2024, 2017 View on Google Scholar ↗ |
2017 | 351 | 95.2% |
|
Mechanism of foreign DNA selection in a bacterial adaptive immune system
Molecular cell 46 (5), 606-615, 2012 View on Google Scholar ↗ |
2012 | 456 | 95.1% |
|
A broad-spectrum inhibitor of CRISPR-Cas9
Cell 170 (6), 1224-1233. e15, 2017 View on Google Scholar ↗ |
2017 | 346 | 95.1% |
|
Hepatitis C Virus IRES RNA-Induced Changes in the Conformation of the 40S Ribosomal Subunit
Science 291 (5510), 1959-1962, 2001 View on Google Scholar ↗ |
2001 | 688 | 95.1% |
|
Endoribonuclease compositions and methods of use thereof
US Patent 9,115,348, 2015 View on Google Scholar ↗ |
2015 | 382 | 95.0% |
|
Dicer-TRBP complex formation ensures accurate mammalian microRNA biogenesis
Molecular cell 57 (3), 397-407, 2015 View on Google Scholar ↗ |
2015 | 382 | 95.0% |
|
RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus
Molecular cell 56 (4), 518-530, 2014 View on Google Scholar ↗ |
2014 | 397 | 95.0% |
|
Rewriting a genome
Nature 495 (7439), 50-51, 2013 View on Google Scholar ↗ |
2013 | 417 | 94.9% |
|
CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
Nucleic acids research 50 (3), 1256-1268, 2022 View on Google Scholar ↗ |
2022 | 96 | 94.9% |
|
ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing
Nature methods 13 (12), 1013-1020, 2016 View on Google Scholar ↗ |
2016 | 348 | 94.9% |
|
Methods of generating nucleic acid fragments
US Patent 10,087,431, 2018 View on Google Scholar ↗ |
2018 | 308 | 94.8% |
|
CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes
Nucleic acids research 52 (D1), D590-D596, 2024 View on Google Scholar ↗ |
2024 | 54 | 94.8% |
|
Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9
Nature communications 7 (1), 12778, 2016 View on Google Scholar ↗ |
2016 | 339 | 94.7% |
|
Tertiary motifs in RNA structure and folding
Angewandte Chemie International Edition 38 (16), 2326-2343, 1999 View on Google Scholar ↗ |
1999 | 631 | 94.7% |
|
Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity
Molecular cell 82 (6), 1199-1209. e6, 2022 View on Google Scholar ↗ |
2022 | 93 | 94.7% |
|
Genome editing in plants using the compact editor CasΦ
Proceedings of the National Academy of Sciences 120 (4), e2216822120, 2023 View on Google Scholar ↗ |
2023 | 63 | 94.6% |
|
Adaptive strategies of the influenza virus polymerase for replication in humans
Proceedings of the National Academy of Sciences 106 (50), 21312-21316, 2009 View on Google Scholar ↗ |
2009 | 493 | 94.6% |
|
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
Nature communications 10 (1), 2127, 2019 View on Google Scholar ↗ |
2019 | 232 | 94.5% |
|
Ribozyme structures and mechanisms
Annual review of biochemistry 69 (1), 597-615, 2000 View on Google Scholar ↗ |
2000 | 649 | 94.5% |
|
Sequential membrane-and protein-bound organelles compartmentalize genomes during phage infection
Cell host & microbe 33 (4), 484-497. e6, 2025 View on Google Scholar ↗ |
2025 | 45 | 94.3% |
|
Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing
Nucleic Acids Research 53 (5), gkaf105, 2025 View on Google Scholar ↗ |
2025 | 45 | 94.3% |
|
RNA-based recognition and targeting: sowing the seeds of specificity
Nature Reviews Molecular Cell Biology 18 (4), 215-228, 2017 View on Google Scholar ↗ |
2017 | 300 | 94.2% |
|
Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid
Nucleic Acids Research 52 (11), 6647-6661, 2024 View on Google Scholar ↗ |
2024 | 48 | 94.1% |
|
Animal and bacterial viruses share conserved mechanisms of immune evasion
Cell 187 (20), 5530-5539. e8, 2024 View on Google Scholar ↗ |
2024 | 48 | 94.1% |
|
DNA interference states of the hypercompact CRISPR–CasΦ effector
Nature structural & molecular biology 28 (8), 652-661, 2021 View on Google Scholar ↗ |
2021 | 132 | 94.1% |
|
Temporal photoproximity labeling of ligand-activated EGFR neighborhoods using MultiMap
Nature Chemical Biology 22 (2), 192-204, 2026 View on Google Scholar ↗ |
2026 | 26 | 93.9% |
|
Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
elife 5, e13450, 2016 View on Google Scholar ↗ |
2016 | 297 | 93.8% |
|
Ancient origin of cGAS-STING reveals mechanism of universal 2′, 3′ cGAMP signaling
Molecular cell 59 (6), 891-903, 2015 View on Google Scholar ↗ |
2015 | 320 | 93.8% |
|
Structural determinants of RNA recognition and cleavage by Dicer
Nature structural & molecular biology 14 (10), 934-940, 2007 View on Google Scholar ↗ |
2007 | 467 | 93.8% |
|
Borgs are giant genetic elements with potential to expand metabolic capacity
Nature 610 (7933), 731-736, 2022 View on Google Scholar ↗ |
2022 | 81 | 93.7% |
|
Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
Molecular Therapy 31 (8), 2422-2438, 2023 View on Google Scholar ↗ |
2023 | 54 | 93.7% |
|
Kinetic analysis of Cas12a and Cas13a RNA-Guided nucleases for development of improved CRISPR-Based diagnostics
Iscience 24 (9), 2021 View on Google Scholar ↗ |
2021 | 124 | 93.6% |
|
RNA language models predict mutations that improve RNA function
Nature communications 15 (1), 10627, 2024 View on Google Scholar ↗ |
2024 | 44 | 93.6% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/206,319, 2014 View on Google Scholar ↗ |
2014 | 321 | 93.6% |
|
RNA tertiary structure mediation by adenosine platforms
Science 273 (5282), 1696-1699, 1996 View on Google Scholar ↗ |
1996 | 479 | 93.6% |
|
A thermostable Cas9 with increased lifetime in human plasma
Nature communications 8 (1), 1424, 2017 View on Google Scholar ↗ |
2017 | 273 | 93.6% |
|
High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding
Proceedings of the National Academy of Sciences 114 (21), 5461-5466, 2017 View on Google Scholar ↗ |
2017 | 268 | 93.4% |
|
Engineered TnpB genome editors for plants and human cells identified by ribonucleoprotein mutational scanning
Nature biotechnology, 1-9, 2026 View on Google Scholar ↗ |
2026 | 23 | 93.3% |
|
Phage-based delivery of CRISPR-associated transposases for targeted bacterial editing
Proceedings of the National Academy of Sciences 122 (30), e2504853122, 2025 View on Google Scholar ↗ |
2025 | 38 | 93.2% |
|
RNA-dependent RNA targeting by CRISPR-Cas9
elife 7, e32724, 2018 View on Google Scholar ↗ |
2018 | 239 | 93.1% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 11,312,953, 2022 View on Google Scholar ↗ |
2022 | 75 | 93.1% |
|
An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3
Nature structural & molecular biology 18 (6), 680-687, 2011 View on Google Scholar ↗ |
2011 | 371 | 93.1% |
|
CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d
Nature Microbiology 10 (3), 694-709, 2025 View on Google Scholar ↗ |
2025 | 37 | 93.1% |
|
Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
Nature biotechnology 34 (6), 646-651, 2016 View on Google Scholar ↗ |
2016 | 267 | 93.1% |
|
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
Journal of Biological Chemistry 295 (42), 14473-14487, 2020 View on Google Scholar ↗ |
2020 | 161 | 93.0% |
|
RNA-guided nucleic acid modifying enzymes and methods of use thereof
US Patent 11,873,504, 2024 View on Google Scholar ↗ |
2024 | 40 | 93.0% |
|
CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference
Proceedings of the National Academy of Sciences 111 (18), 6618-6623, 2014 View on Google Scholar ↗ |
2014 | 297 | 92.9% |
|
Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus
Molecular cell 52 (1), 135-145, 2013 View on Google Scholar ↗ |
2013 | 320 | 92.9% |
|
The structural biology of CRISPR-Cas systems
Current opinion in structural biology 30, 100-111, 2015 View on Google Scholar ↗ |
2015 | 281 | 92.8% |
|
SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation
PLoS pathogens 20 (11), e1012741, 2024 View on Google Scholar ↗ |
2024 | 39 | 92.8% |
|
Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing
Nucleic acids research 41 (13), 6568-6576, 2013 View on Google Scholar ↗ |
2013 | 316 | 92.8% |
|
Systematic discovery of natural CRISPR-Cas12a inhibitors
Science 362 (6411), 236-239, 2018 View on Google Scholar ↗ |
2018 | 228 | 92.7% |
|
Foreign DNA capture during CRISPR–Cas adaptive immunity
Nature 527 (7579), 535-538, 2015 View on Google Scholar ↗ |
2015 | 276 | 92.7% |
|
Mechanism of ribosome recruitment by hepatitis C IRES RNA
Rna 7 (2), 194-206, 2001 View on Google Scholar ↗ |
2001 | 500 | 92.6% |
|
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
Proceedings of the National Academy of Sciences 116 (16), 7899-7904, 2019 View on Google Scholar ↗ |
2019 | 180 | 92.6% |
|
Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing
Molecular cell 85 (9), 1730-1742. e9, 2025 View on Google Scholar ↗ |
2025 | 35 | 92.6% |
|
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression
Cell 184 (3), 844, 2021 View on Google Scholar ↗ |
2021 | 108 | 92.5% |
|
Crystal structure of the ribonucleoprotein core of the signal recognition particle
Science 287 (5456), 1232-1239, 2000 View on Google Scholar ↗ |
2000 | 493 | 92.5% |
|
Targeted delivery of genome editors in vivo
Nature biotechnology 44 (1), 49-59, 2026 View on Google Scholar ↗ |
2026 | 20 | 92.4% |
|
Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme
Nature structural & molecular biology 24 (10), 825-833, 2017 View on Google Scholar ↗ |
2017 | 235 | 92.4% |
|
A magnesium ion core at the heart of a ribozyme domain
Nature structural biology 4 (7), 553-558, 1997 View on Google Scholar ↗ |
1997 | 428 | 92.3% |
|
A miniature CRISPR–Cas10 enzyme confers immunity by inhibitory signalling
Nature 647 (8091), 997-1004, 2025 View on Google Scholar ↗ |
2025 | 34 | 92.3% |
|
Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated genome defense
Structure 17 (6), 904-912, 2009 View on Google Scholar ↗ |
2009 | 366 | 92.3% |
|
Decorating chromatin for enhanced genome editing using CRISPR-Cas9
Proceedings of the National Academy of Sciences 119 (49), e2204259119, 2022 View on Google Scholar ↗ |
2022 | 68 | 92.3% |
|
Eukaryotic RNA-guided endonucleases evolved from a unique clade of bacterial enzymes
Nucleic acids research 51 (22), 12414-12427, 2023 View on Google Scholar ↗ |
2023 | 44 | 92.2% |
|
Surveillance and processing of foreign DNA by the Escherichia coli CRISPR-Cas system
Cell 163 (4), 854-865, 2015 View on Google Scholar ↗ |
2015 | 262 | 92.2% |
|
Structural insights into RNA processing by the human RISC-loading complex
Nature structural & molecular biology 16 (11), 1148-1153, 2009 View on Google Scholar ↗ |
2009 | 361 | 92.2% |
|
Receptor-mediated delivery of CRISPR-Cas9 endonuclease for cell-type-specific gene editing
Journal of the American Chemical Society 140 (21), 6596-6603, 2018 View on Google Scholar ↗ |
2018 | 206 | 91.9% |
|
Assembly of SARS-CoV-2 ribonucleosomes by truncated N∗ variant of the nucleocapsid protein
Journal of Biological Chemistry 299 (12), 2023 View on Google Scholar ↗ |
2023 | 42 | 91.8% |
|
Infant microbiome cultivation and metagenomic analysis reveal Bifidobacterium 2’-fucosyllactose utilization can be facilitated by coexisting species
Nature Communications 14 (1), 7417, 2023 View on Google Scholar ↗ |
2023 | 42 | 91.8% |
|
Mechanism-guided engineering of a minimal biological particle for genome editing
Proceedings of the National Academy of Sciences 122 (1), e2413519121, 2025 View on Google Scholar ↗ |
2025 | 32 | 91.8% |
|
CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks
elife 9, e55143, 2020 View on Google Scholar ↗ |
2020 | 139 | 91.8% |
|
CRISPR germline engineering—the community speaks
Nature biotechnology 33 (5), 478-486, 2015 View on Google Scholar ↗ |
2015 | 247 | 91.7% |
|
A phage nucleus-associated RNA-binding protein is required for jumbo phage infection
Nucleic acids research 52 (8), 4440-4455, 2024 View on Google Scholar ↗ |
2024 | 34 | 91.7% |
|
Genome expansion by a CRISPR trimmer-integrase
Nature 618 (7966), 855-861, 2023 View on Google Scholar ↗ |
2023 | 41 | 91.7% |
|
CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors
Nucleic Acids Research 50 (15), 8986-8998, 2022 View on Google Scholar ↗ |
2022 | 63 | 91.6% |
|
RNA binding and HEPN-nuclease activation are decoupled in CRISPR-Cas13a
Cell Reports 24 (4), 1025-1036, 2018 View on Google Scholar ↗ |
2018 | 199 | 91.5% |
|
RNA processing enables predictable programming of gene expression
Nature biotechnology 30 (10), 1002-1006, 2012 View on Google Scholar ↗ |
2012 | 291 | 91.5% |
|
A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells
Cell reports 17 (5), 1438-1452, 2016 View on Google Scholar ↗ |
2016 | 223 | 91.5% |
|
RNA-guided nucleic acid modifying enzymes and methods of use thereof
US Patent 11,795,472, 2023 View on Google Scholar ↗ |
2023 | 40 | 91.4% |
|
A functional map of HIV-host interactions in primary human T cells
Nature communications 13 (1), 1752, 2022 View on Google Scholar ↗ |
2022 | 62 | 91.4% |
|
Machine learning predicts new anti-CRISPR proteins
Nucleic acids research 48 (9), 4698-4708, 2020 View on Google Scholar ↗ |
2020 | 133 | 91.4% |
|
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
Nature protocols 14 (1), 1-27, 2019 View on Google Scholar ↗ |
2019 | 157 | 91.4% |
|
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
Proceedings of the National Academy of Sciences 117 (11), 5853-5860, 2020 View on Google Scholar ↗ |
2020 | 132 | 91.3% |
|
CRISPR immunological memory requires a host factor for specificity
Molecular cell 62 (6), 824-833, 2016 View on Google Scholar ↗ |
2016 | 219 | 91.3% |
|
RNA-catalysed synthesis of complementary-strand RNA
Nature 339 (6225), 519-522, 1989 View on Google Scholar ↗ |
1989 | 317 | 91.3% |
|
A conformational switch controls hepatitis delta virus ribozyme catalysis
Nature 429 (6988), 201-205, 2004 View on Google Scholar ↗ |
2004 | 385 | 91.1% |
|
Ribonuclease revisited: structural insights into ribonuclease III family enzymes
Current opinion in structural biology 17 (1), 138-145, 2007 View on Google Scholar ↗ |
2007 | 341 | 91.0% |
|
Coupled 5′ nucleotide recognition and processivity in Xrn1-mediated mRNA decay
Molecular cell 41 (5), 600-608, 2011 View on Google Scholar ↗ |
2011 | 293 | 90.9% |
|
A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression
Molecular cell 82 (11), 2148-2160. e4, 2022 View on Google Scholar ↗ |
2022 | 59 | 90.9% |
|
Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3
Proceedings of the National Academy of Sciences 105 (47), 18139-18144, 2008 View on Google Scholar ↗ |
2008 | 324 | 90.9% |
|
Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions
Genetics 195 (2), 331-348, 2013 View on Google Scholar ↗ |
2013 | 256 | 90.7% |
|
A bacterial Argonaute with noncanonical guide RNA specificity
Proceedings of the National Academy of Sciences 113 (15), 4057-4062, 2016 View on Google Scholar ↗ |
2016 | 206 | 90.6% |
|
Broad-spectrum enzymatic inhibition of CRISPR-Cas12a
Nature structural & molecular biology 26 (4), 315-321, 2019 View on Google Scholar ↗ |
2019 | 146 | 90.6% |
|
Structural and mechanistic insights into hepatitis C viral translation initiation
Nature Reviews Microbiology 5 (1), 29-38, 2007 View on Google Scholar ↗ |
2007 | 327 | 90.6% |
|
Directed evolution expands CRISPR–Cas12a genome-editing capacity
Nucleic Acids Research 53 (13), gkaf649, 2025 View on Google Scholar ↗ |
2025 | 28 | 90.5% |
|
Structural roles for human translation factor eIF3 in initiation of protein synthesis
Science 310 (5753), 1513-1515, 2005 View on Google Scholar ↗ |
2005 | 347 | 90.5% |
|
Autoinhibition of human dicer by its internal helicase domain
Journal of molecular biology 380 (1), 237-243, 2008 View on Google Scholar ↗ |
2008 | 312 | 90.5% |
|
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
Acta Biomaterialia 114, 358-368, 2020 View on Google Scholar ↗ |
2020 | 120 | 90.4% |
|
Widespread translational remodeling during human neuronal differentiation
Cell reports 21 (7), 2005-2016, 2017 View on Google Scholar ↗ |
2017 | 182 | 89.9% |
|
Deciphering off-target effects in CRISPR-Cas9 through accelerated molecular dynamics
ACS central science 5 (4), 651, 2019 View on Google Scholar ↗ |
2019 | 136 | 89.9% |
|
The chemistry of Cas9 and its CRISPR colleagues
Nature Reviews Chemistry 1 (10), 0078, 2017 View on Google Scholar ↗ |
2017 | 181 | 89.9% |
|
Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysis
Cell reports 42 (11), 2023 View on Google Scholar ↗ |
2023 | 34 | 89.8% |
|
Metal-binding sites in the major groove of a large ribozyme domain
Structure 4 (10), 1221-1229, 1996 View on Google Scholar ↗ |
1996 | 314 | 89.8% |
|
Human molecular genetics and genomics—important advances and exciting possibilities
New England Journal of Medicine 384 (1), 1-4, 2021 View on Google Scholar ↗ |
2021 | 82 | 89.8% |
|
CRISPR-Cas9 circular permutants as programmable scaffolds for genome modification
Cell 176 (1), 254-267. e16, 2019 View on Google Scholar ↗ |
2019 | 132 | 89.5% |
|
Site-specific bioconjugation through enzyme-catalyzed tyrosine–cysteine bond formation
ACS Central Science 6 (9), 1564, 2020 View on Google Scholar ↗ |
2020 | 108 | 89.2% |
|
A unified resource for tracking anti-CRISPR names
The CRISPR journal 1 (5), 304-305, 2018 View on Google Scholar ↗ |
2018 | 158 | 89.2% |
|
An essential and highly selective protein import pathway encoded by nucleus-forming phage
Proceedings of the National Academy of Sciences 121 (19), e2321190121, 2024 View on Google Scholar ↗ |
2024 | 26 | 89.2% |
|
Structures of the CRISPR genome integration complex
Science 357 (6356), 1113-1118, 2017 View on Google Scholar ↗ |
2017 | 170 | 89.1% |
|
Disruption of the β1L isoform of GABP reverses glioblastoma replicative immortality in a TERT promoter mutation-dependent manner
Cancer cell 34 (3), 513-528. e8, 2018 View on Google Scholar ↗ |
2018 | 157 | 89.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
2016 View on Google Scholar ↗ |
2016 | 179 | 89.0% |
|
Characterizing and controlling CRISPR repair outcomes in nondividing human cells
Nature communications 16 (1), 9883, 2025 View on Google Scholar ↗ |
2025 | 24 | 89.0% |
|
Mechanism of substrate selection by a highly specific CRISPR endoribonuclease
Rna 18 (4), 661-672, 2012 View on Google Scholar ↗ |
2012 | 232 | 89.0% |
|
Cap-independent translation is required for starvation-induced differentiation in yeast
science 317 (5842), 1224-1227, 2007 View on Google Scholar ↗ |
2007 | 283 | 88.9% |
|
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
PLoS biology 15 (3), e2001882, 2017 View on Google Scholar ↗ |
2017 | 167 | 88.9% |
|
TRBP alters human precursor microRNA processing in vitro
Rna 18 (11), 2012-2019, 2012 View on Google Scholar ↗ |
2012 | 229 | 88.8% |
|
The psychiatric cell map initiative: a convergent systems biological approach to illuminating key molecular pathways in neuropsychiatric disorders
Cell 174 (3), 505-520, 2018 View on Google Scholar ↗ |
2018 | 153 | 88.8% |
|
Key role of the REC lobe during CRISPR–Cas9 activation by ‘sensing’,‘regulating’, and ‘locking’the catalytic HNH domain
Quarterly reviews of biophysics 51, e9, 2018 View on Google Scholar ↗ |
2018 | 152 | 88.7% |
|
A universal mode of helix packing in RNA
Nature structural biology 8 (4), 339-343, 2001 View on Google Scholar ↗ |
2001 | 324 | 88.5% |
|
Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning
Science 348 (6234), 581-585, 2015 View on Google Scholar ↗ |
2015 | 187 | 88.5% |
|
Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement
Science advances 7 (8), eabe5496, 2021 View on Google Scholar ↗ |
2021 | 73 | 88.3% |
|
The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold
Journal of molecular biology 292 (3), 513-529, 1999 View on Google Scholar ↗ |
1999 | 307 | 88.2% |
|
Cutting it close: CRISPR-associated endoribonuclease structure and function
Trends in biochemical sciences 40 (1), 58-66, 2015 View on Google Scholar ↗ |
2015 | 182 | 88.2% |
|
Applications of CRISPR-Cas enzymes in cancer therapeutics and detection
Trends in cancer 4 (7), 499-512, 2018 View on Google Scholar ↗ |
2018 | 145 | 88.2% |
|
Functional protein mining with conformal guarantees
Nature Communications 16 (1), 85, 2025 View on Google Scholar ↗ |
2025 | 22 | 88.0% |
|
Single-stranded DNA cleavage by divergent CRISPR-Cas9 enzymes
Molecular cell 60 (3), 398-407, 2015 View on Google Scholar ↗ |
2015 | 175 | 87.6% |
|
Dynamic basis of supercoiling-dependent DNA interrogation by Cas12a via R-loop intermediates
Nature communications 16 (1), 2939, 2025 View on Google Scholar ↗ |
2025 | 21 | 87.4% |
|
Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules
Nature Communications 12 (1), 5664, 2021 View on Google Scholar ↗ |
2021 | 67 | 87.1% |
|
A specific monovalent metal ion integral to the AA platform of the RNA tetraloop receptor
nature structural biology 5 (11), 986-992, 1998 View on Google Scholar ↗ |
1998 | 268 | 87.1% |
|
Recurrent acquisition of nuclease-protease pairs in antiviral immunity
Science 391 (6781), 195-201, 2026 View on Google Scholar ↗ |
2026 | 12 | 86.9% |
|
Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA
Proceedings of the National Academy of Sciences 101 (49), 16990-16995, 2004 View on Google Scholar ↗ |
2004 | 269 | 86.9% |
|
Neuronal DNA repair reveals strategies to influence CRISPR editing outcomes
BioRxiv, 2024.06. 25.600517, 2025 View on Google Scholar ↗ |
2025 | 20 | 86.9% |
|
A scoutRNA is required for some type V CRISPR-Cas systems
Molecular Cell 79 (3), 416-424. e5, 2020 View on Google Scholar ↗ |
2020 | 91 | 86.9% |
|
Methods and compositions for detecting a target RNA
US Patent 11,827,919, 2023 View on Google Scholar ↗ |
2023 | 26 | 86.6% |
|
Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers
Journal of virology 86 (3), 1750-1757, 2012 View on Google Scholar ↗ |
2012 | 193 | 86.5% |
|
Multiple sensors ensure guide strand selection in human RNAi pathways
Rna 19 (5), 639-648, 2013 View on Google Scholar ↗ |
2013 | 182 | 86.4% |
|
siRNA repositioning for guide strand selection by human Dicer complexes
Molecular cell 43 (1), 110-121, 2011 View on Google Scholar ↗ |
2011 | 202 | 86.4% |
|
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Proceedings of the National Academy of Sciences 118 (13), e2008772118, 2021 View on Google Scholar ↗ |
2021 | 63 | 86.3% |
|
CRISPR-Cas12a bends DNA to destabilize base pairs during target interrogation
Nucleic acids research 53 (2), gkae1192, 2025 View on Google Scholar ↗ |
2025 | 19 | 86.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,301,651, 2019 View on Google Scholar ↗ |
2019 | 101 | 86.1% |
|
Oligomeric State and Drug Binding of the SARS-CoV‑2 Envelope Protein Are Sensitive to the Ectodomain
Journal of the American Chemical Society 146 (35), 24537-24552, 2024 View on Google Scholar ↗ |
2024 | 20 | 86.0% |
|
An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase
Cell host & microbe 4 (2), 111-122, 2008 View on Google Scholar ↗ |
2008 | 217 | 85.9% |
|
RNA-guided nucleic acid modifying enzymes and methods of use thereof
US Patent 10,570,415, 2020 View on Google Scholar ↗ |
2020 | 85 | 85.9% |
|
Temperature-responsive competitive inhibition of CRISPR-Cas9
Molecular cell 73 (3), 601-610. e5, 2019 View on Google Scholar ↗ |
2019 | 99 | 85.8% |
|
Protecting genome integrity during CRISPR immune adaptation
Nature structural & molecular biology 23 (10), 876-883, 2016 View on Google Scholar ↗ |
2016 | 141 | 85.8% |
|
Structure-guided reprogramming of human cGAS dinucleotide linkage specificity
Cell 158 (5), 1011-1021, 2014 View on Google Scholar ↗ |
2014 | 160 | 85.7% |
|
Substrate-specific kinetics of Dicer-catalyzed RNA processing
Journal of molecular biology 404 (3), 392-402, 2010 View on Google Scholar ↗ |
2010 | 208 | 85.6% |
|
Identification of proteins influencing CRISPR-associated transposases for enhanced genome editing
Science Advances 12 (1), eaea1429, 2026 View on Google Scholar ↗ |
2026 | 11 | 85.5% |
|
Programmable kinetic barcoding for multiplexed RNA detection with Cas13a
Nature Biomedical Engineering, 1-12, 2026 View on Google Scholar ↗ |
2026 | 11 | 85.5% |
|
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
US Patent 10,253,365, 2019 View on Google Scholar ↗ |
2019 | 97 | 85.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,227,611, 2019 View on Google Scholar ↗ |
2019 | 97 | 85.5% |
|
Use of Cis- and Trans-Ribozymes to Remove 5′ and 3′ Heterogeneities From Milligrams of In Vitro Transcribed RNA
Nucleic acids research 24 (5), 977-978, 1996 View on Google Scholar ↗ |
1996 | 221 | 85.4% |
|
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
US Patent 11,447,824, 2022 View on Google Scholar ↗ |
2022 | 38 | 85.3% |
|
Specificity for aminoacylation of an RNA helix: an unpaired, exocyclic amino group in the minor groove
Science 253 (5021), 784-786, 1991 View on Google Scholar ↗ |
1991 | 198 | 85.2% |
|
Direct link between RACK1 function and localization at the ribosome in vivo
Molecular and cellular biology 29 (6), 1626-1634, 2009 View on Google Scholar ↗ |
2009 | 198 | 85.0% |
|
Chemical and biophysical modulation of Cas9 for tunable genome engineering
ACS chemical biology 11 (3), 681-688, 2016 View on Google Scholar ↗ |
2016 | 134 | 85.0% |
|
Methods and compositions for detecting a target RNA
US Patent 11,459,600, 2022 View on Google Scholar ↗ |
2022 | 37 | 84.9% |
|
Crystallization of RNA and RNA–protein complexes
Methods 34 (3), 408-414, 2004 View on Google Scholar ↗ |
2004 | 233 | 84.8% |
|
Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
Proceedings of the National Academy of Sciences 117 (12), 6531-6539, 2020 View on Google Scholar ↗ |
2020 | 79 | 84.8% |
|
The crystal structure of the signal recognition particle in complex with its receptor
Science 331 (6019), 881-886, 2011 View on Google Scholar ↗ |
2011 | 182 | 84.7% |
|
Genomes in focus: development and applications of CRISPR‐Cas9 imaging technologies
Angewandte Chemie International Edition 57 (16), 4329-4337, 2018 View on Google Scholar ↗ |
2018 | 112 | 84.7% |
|
Ribozyme catalysis: not different, just worse
Nature structural & molecular biology 12 (5), 395-402, 2005 View on Google Scholar ↗ |
2005 | 220 | 84.6% |
|
dsRNA with 5′ overhangs contributes to endogenous and antiviral RNA silencing pathways in plants
The EMBO journal 28 (5), 545, 2009 View on Google Scholar ↗ |
2009 | 192 | 84.5% |
|
RNA structure, not sequence, determines the 5'splice-site specificity of a group I intron.
Proceedings of the National Academy of Sciences 86 (19), 7402-7406, 1989 View on Google Scholar ↗ |
1989 | 176 | 84.3% |
|
Structure and function of the eukaryotic ribosome: the next frontier
Cell 109 (2), 153-156, 2002 View on Google Scholar ↗ |
2002 | 232 | 84.2% |
|
Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation
Nature structural biology 9 (5), 370-374, 2002 View on Google Scholar ↗ |
2002 | 232 | 84.2% |
|
Treatment of genetic diseases with CRISPR genome editing
Jama 328 (10), 980-981, 2022 View on Google Scholar ↗ |
2022 | 35 | 84.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,000,772, 2018 View on Google Scholar ↗ |
2018 | 106 | 83.8% |
|
Autoinhibitory interdomain interactions and subfamily-specific extensions redefine the catalytic core of the human DEAD-box protein DDX3
Journal of Biological Chemistry 291 (5), 2412-2421, 2016 View on Google Scholar ↗ |
2016 | 124 | 83.7% |
|
A multisubunit ribozyme that is a catalyst of and template for complementary strand RNA synthesis
Science 251 (5001), 1605-1608, 1991 View on Google Scholar ↗ |
1991 | 176 | 83.6% |
|
Crystallization of ribozymes and small RNA motifs by a sparse matrix approach.
Proceedings of the National Academy of Sciences 90 (16), 7829-7833, 1993 View on Google Scholar ↗ |
1993 | 174 | 83.5% |
|
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2
Nature communications 10 (1), 2806, 2019 View on Google Scholar ↗ |
2019 | 85 | 83.4% |
|
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
Nucleic acids research 45 (11), e98-e98, 2017 View on Google Scholar ↗ |
2017 | 112 | 83.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,407,697, 2019 View on Google Scholar ↗ |
2019 | 84 | 83.2% |
|
Substrate-specific structural rearrangements of human Dicer
Nature structural & molecular biology 20 (6), 662-670, 2013 View on Google Scholar ↗ |
2013 | 147 | 83.2% |
|
Crystallization and structure determination of a hepatitis delta virus ribozyme: use of the RNA-binding protein U1A as a crystallization module
Journal of molecular biology 295 (3), 541-556, 2000 View on Google Scholar ↗ |
2000 | 221 | 83.0% |
|
DNA targeting by a minimal CRISPR RNA-guided cascade
Molecular cell 63 (5), 840-851, 2016 View on Google Scholar ↗ |
2016 | 117 | 82.8% |
|
Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR RNA
The EMBO journal 31 (12), 2824-2832, 2012 View on Google Scholar ↗ |
2012 | 150 | 82.5% |
|
Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies
Molecular cell 44 (5), 745-758, 2011 View on Google Scholar ↗ |
2011 | 159 | 82.5% |
|
CRISPR-cas effector polypeptides and methods of use thereof
US Patent 12,674,149, 2026 View on Google Scholar ↗ |
2026 | 9 | 82.4% |
|
Structure and evolution-guided design of minimal RNA-guided nucleases
Science 393 (6808), 313-318, 2026 View on Google Scholar ↗ |
2026 | 9 | 82.4% |
|
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress
Oncotarget 7 (19), 28169, 2016 View on Google Scholar ↗ |
2016 | 114 | 82.3% |
|
RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System
PloS one 12 (1), e0170552, 2017 View on Google Scholar ↗ |
2017 | 105 | 82.1% |
|
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 RNP
BioRxiv, 2023.11. 15.566339, 2023 View on Google Scholar ↗ |
2023 | 19 | 82.0% |
|
Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases
Nucleic acids research 42 (2), 1341-1353, 2013 View on Google Scholar ↗ |
2013 | 136 | 81.8% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/749,594, 2016 View on Google Scholar ↗ |
2016 | 110 | 81.7% |
|
Hachiman is a genome integrity sensor
bioRxiv, 2024 View on Google Scholar ↗ |
2024 | 15 | 81.6% |
|
eIF3j is located in the decoding center of the human 40S ribosomal subunit
Molecular cell 26 (6), 811-819, 2007 View on Google Scholar ↗ |
2007 | 172 | 81.6% |
|
Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry
Molecular & Cellular Proteomics 6 (7), 1135-1146, 2007 View on Google Scholar ↗ |
2007 | 171 | 81.5% |
|
Methods and compositions for detecting a target RNA
US Patent 10,337,051, 2019 View on Google Scholar ↗ |
2019 | 76 | 81.4% |
|
Methods and compositions for detecting a target RNA
US Patent 11,840,725, 2023 View on Google Scholar ↗ |
2023 | 18 | 81.1% |
|
Genome-wide characterization of diverse bacteriophages enabled by RNA-binding CRISPRi
bioRxiv, 2023.09. 18.558157, 2023 View on Google Scholar ↗ |
2023 | 18 | 81.1% |
|
Crystal structure of the HCV IRES central domain reveals strategy for start-codon positioning
Structure 19 (10), 1456-1466, 2011 View on Google Scholar ↗ |
2011 | 145 | 80.9% |
|
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells
Nature Biotechnology, 1-15, 2026 View on Google Scholar ↗ |
2026 | 8 | 80.9% |
|
Efficient transgene‐free multiplexed germline editing via viral delivery of an engineered TnpB
Plant Biotechnology Journal 24 (6), 4358-4360, 2026 View on Google Scholar ↗ |
2026 | 8 | 80.9% |
|
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Nature communications 13 (1), 5430, 2022 View on Google Scholar ↗ |
2022 | 29 | 80.8% |
|
Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation
Nature structural & molecular biology 17 (2), 238-240, 2010 View on Google Scholar ↗ |
2010 | 155 | 80.8% |
|
Metal ions in ribozyme folding and catalysis
Current opinion in chemical biology 4 (2), 166-170, 2000 View on Google Scholar ↗ |
2000 | 191 | 80.8% |
|
Methods and compositions for controlling gene expression by RNA processing
US Patent 9,745,610, 2017 View on Google Scholar ↗ |
2017 | 97 | 80.7% |
|
Stereochemical course of catalysis by the Tetrahymena ribozyme
Science 244 (4905), 692-694, 1989 View on Google Scholar ↗ |
1989 | 140 | 80.6% |
|
Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
Epidemics 37, 100527, 2021 View on Google Scholar ↗ |
2021 | 45 | 80.6% |
|
Mechanistic basis of atypical TERT promoter mutations
Nature Communications 15 (1), 9965, 2024 View on Google Scholar ↗ |
2024 | 14 | 80.5% |
|
Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
US Patent 12,275,964, 2025 View on Google Scholar ↗ |
2025 | 13 | 80.3% |
|
Divergent viral phosphodiesterases for immune signaling evasion
Cell host & microbe 33 (12), 2043-2051. e6, 2025 View on Google Scholar ↗ |
2025 | 13 | 80.3% |
|
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
Nucleic acids research 41 (7), 4230-4240, 2013 View on Google Scholar ↗ |
2013 | 125 | 80.3% |
|
Structural insights into the signal recognition particle
Annual review of biochemistry 73 (1), 539-557, 2004 View on Google Scholar ↗ |
2004 | 173 | 80.1% |
|
Self-assembly of a group I intron active site from its component tertiary structural domains
Rna 1 (1), 36, 1995 View on Google Scholar ↗ |
1995 | 150 | 80.0% |
|
Structure of Dicer and mechanistic implications for RNAi
Cold Spring Harbor symposia on quantitative biology 71, 73-80, 2006 View on Google Scholar ↗ |
2006 | 159 | 79.9% |
|
Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3)
Proceedings of the National Academy of Sciences 108 (51), 20473-20478, 2011 View on Google Scholar ↗ |
2011 | 137 | 79.9% |
|
Methods and compositions for using argonaute to modify a single stranded target nucleic acid
US Patent App. 15/129,382, 2017 View on Google Scholar ↗ |
2017 | 92 | 79.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 14/685,516, 2016 View on Google Scholar ↗ |
2016 | 99 | 79.6% |
|
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding
Journal of virology 74 (22), 10430-10437, 2000 View on Google Scholar ↗ |
2000 | 176 | 79.4% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 14/685,513, 2016 View on Google Scholar ↗ |
2016 | 97 | 79.2% |
|
Modeling and automation of sequencing-based characterization of RNA structure
Proceedings of the National Academy of Sciences 108 (27), 11069-11074, 2011 View on Google Scholar ↗ |
2011 | 132 | 79.2% |
|
A general module for RNA crystallization
Journal of molecular biology 279 (3), 621-631, 1998 View on Google Scholar ↗ |
1998 | 157 | 79.1% |
|
Structural genomics of RNA
nature structural biology 7 (11), 954-956, 2000 View on Google Scholar ↗ |
2000 | 173 | 79.1% |
|
Large-scale purification of a stable form of recombinant tobacco etch virus protease
Biotechniques 30 (3), 544-554, 2001 View on Google Scholar ↗ |
2001 | 170 | 79.1% |
|
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
US Patent 11,118,224, 2021 View on Google Scholar ↗ |
2021 | 41 | 78.8% |
|
Blueprint for a pop-up SARS-CoV-2 testing lab
Nature Biotechnology 38 (7), 791-797, 2020 View on Google Scholar ↗ |
2020 | 56 | 78.8% |
|
RNA-guided nucleic acid modifying enzymes and methods of use thereof
US Patent 12,637,691, 2026 View on Google Scholar ↗ |
2026 | 7 | 78.7% |
|
The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40 S ribosomal subunits in vitro
Journal of Biological Chemistry 279 (10), 8946-8956, 2004 View on Google Scholar ↗ |
2004 | 160 | 78.6% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 14/685,514, 2016 View on Google Scholar ↗ |
2016 | 94 | 78.6% |
|
RNA-guided assembly of Rev-RRE nuclear export complexes
Elife 3, e03656, 2014 View on Google Scholar ↗ |
2014 | 106 | 78.3% |
|
Synthesis of multi-protein complexes through charge-directed sequential activation of tyrosine residues
Journal of the American Chemical Society 143 (34), 13538, 2021 View on Google Scholar ↗ |
2021 | 39 | 77.8% |
|
Cas9 crystals and methods of use thereof
US Patent 9,963,689, 2018 View on Google Scholar ↗ |
2018 | 75 | 77.6% |
|
Structural insights into RNA interference
Current opinion in structural biology 20 (1), 90-97, 2010 View on Google Scholar ↗ |
2010 | 130 | 77.5% |
|
Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
Nature communications 10 (1), 3001, 2019 View on Google Scholar ↗ |
2019 | 62 | 77.5% |
|
RNA folds: insights from recent crystal structures
Annual review of biophysics and biomolecular structure 28 (1), 57-73, 1999 View on Google Scholar ↗ |
1999 | 148 | 77.4% |
|
Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor.
Proceedings of the National Academy of Sciences 92 (6), 2355-2359, 1995 View on Google Scholar ↗ |
1995 | 127 | 77.3% |
|
Engineering improved Cas13 effectors for targeted post-transcriptional regulation of gene expression
BioRxiv, 2021.05. 26.445687, 2021 View on Google Scholar ↗ |
2021 | 38 | 77.3% |
|
Methods and compositions for detecting a target RNA
US Patent 10,494,664, 2019 View on Google Scholar ↗ |
2019 | 61 | 77.2% |
|
DNA recognition by an RNA-guided bacterial Argonaute
PloS one 12 (5), e0177097, 2017 View on Google Scholar ↗ |
2017 | 81 | 77.1% |
|
The crystal structure of augmenter of liver regeneration: a mammalian FAD‐dependent sulfhydryl oxidase
Protein science 12 (5), 1109-1118, 2003 View on Google Scholar ↗ |
2003 | 149 | 77.0% |
|
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a
elife 8, e49110, 2019 View on Google Scholar ↗ |
2019 | 60 | 76.8% |
|
Direct pKa Measurement of the Active-Site Cytosine in a Genomic Hepatitis Delta Virus Ribozyme
Journal of the American Chemical Society 123 (35), 8447-8452, 2001 View on Google Scholar ↗ |
2001 | 146 | 76.6% |
|
Class 2 CRISPR/Cas compositions and methods of use
US Patent 11,970,719, 2024 View on Google Scholar ↗ |
2024 | 11 | 76.5% |
|
Birth of new protein folds and functions in the virome
bioRxiv, 2024.01. 22.576744, 2024 View on Google Scholar ↗ |
2024 | 11 | 76.5% |
|
RNA–protein analysis using a conditional CRISPR nuclease
Proceedings of the National Academy of Sciences 110 (14), 5416-5421, 2013 View on Google Scholar ↗ |
2013 | 103 | 76.4% |
|
Coordinated activities of human dicer domains in regulatory RNA processing
Journal of molecular biology 422 (4), 466-476, 2012 View on Google Scholar ↗ |
2012 | 107 | 75.9% |
|
Improving RNA secondary structure prediction through expanded training data
RNA 32 (11), 1687-1700, 2026 View on Google Scholar ↗ |
2026 | 6 | 75.7% |
|
Regulation of virion production by the ORF8 signal peptide across SARS-CoV-2 variants
bioRxiv, 2024.03. 05.583578, 2026 View on Google Scholar ↗ |
2026 | 6 | 75.7% |
|
A noncontiguous code for RNA-guided DNA recognition at the origin of CRISPR-Cas
Science 393 (6817), 1230-1235, 2026 View on Google Scholar ↗ |
2026 | 6 | 75.7% |
|
Targeting cancer-specific mutations with RNA-triggered chromatin shredding
Nature, 1-3, 2026 View on Google Scholar ↗ |
2026 | 6 | 75.7% |
|
Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES‐bound complexes
Protein science 14 (6), 1438-1446, 2005 View on Google Scholar ↗ |
2005 | 129 | 75.5% |
|
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
Rna 16 (8), 1559-1569, 2010 View on Google Scholar ↗ |
2010 | 116 | 75.2% |
|
Specificity of RNA–RNA helix recognition
Proceedings of the National Academy of Sciences 99 (18), 11676-11681, 2002 View on Google Scholar ↗ |
2002 | 137 | 75.2% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 9,260,752, 2016 View on Google Scholar ↗ |
2016 | 80 | 75.2% |
|
Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation
Nucleic acids research 41 (15), 7512-7521, 2013 View on Google Scholar ↗ |
2013 | 97 | 75.1% |
|
A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes
Rna 5 (6), 720-727, 1999 View on Google Scholar ↗ |
1999 | 130 | 75.1% |
|
Targeted genome editing of bacteria within microbial communities
BioRxiv, 2020.07. 17.209189, 2020 View on Google Scholar ↗ |
2020 | 47 | 75.0% |
|
Structural insights into group II intron catalysis and branch-site selection
Science 295 (5562), 2084-2088, 2002 View on Google Scholar ↗ |
2002 | 135 | 74.9% |
|
5 Translation Initiation by Viral Internal Ribosome Entry Sites
Cold Spring Harbor Monograph Archive 48, 129-153, 2007 View on Google Scholar ↗ |
2007 | 120 | 74.9% |
|
Mutational analysis of conserved nucleotides in a self-splicing group I intron
Journal of molecular biology 215 (3), 345-358, 1990 View on Google Scholar ↗ |
1990 | 102 | 74.7% |
|
Structural and energetic analysis of RNA recognition by a universally conserved protein from the signal recognition particle
Journal of molecular biology 307 (1), 229-246, 2001 View on Google Scholar ↗ |
2001 | 128 | 74.2% |
|
Latent activity in TnpB revealed by mutational scanning
2025 View on Google Scholar ↗ |
2025 | 9 | 73.9% |
|
CasY compositions and methods of use
US Patent 12,227,753, 2025 View on Google Scholar ↗ |
2025 | 9 | 73.9% |
|
Mutations in Cas9 enhance the rate of acquisition of viral spacer sequences during the CRISPR-Cas immune response
Molecular cell 65 (1), 168-175, 2017 View on Google Scholar ↗ |
2017 | 70 | 73.9% |
|
Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat: AFF4: P-TEFb: TAR complex
Elife 5, e15910, 2016 View on Google Scholar ↗ |
2016 | 75 | 73.7% |
|
A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration
Nucleic acids research 49 (6), 3546-3556, 2021 View on Google Scholar ↗ |
2021 | 32 | 73.4% |
|
CasZ compositions and methods of use
US Patent 11,441,137, 2022 View on Google Scholar ↗ |
2022 | 20 | 73.4% |
|
CASZ compositions and methods of use
US Patent 11,453,866, 2022 View on Google Scholar ↗ |
2022 | 20 | 73.4% |
|
CasZ compositions and methods of use
US Patent 11,371,031, 2022 View on Google Scholar ↗ |
2022 | 20 | 73.4% |
|
Native tandem and ion mobility mass spectrometry highlight structural and modular similarities in clustered-regularly-interspaced shot-palindromic-repeats (CRISPR)-associated …
Molecular & Cellular Proteomics 11 (11), 1430-1441, 2012 View on Google Scholar ↗ |
2012 | 95 | 73.3% |
|
Hepatitis C virus 3′ UTR regulates viral translation through direct interactions with the host translation machinery
Nucleic acids research 41 (16), 7861-7874, 2013 View on Google Scholar ↗ |
2013 | 89 | 73.2% |
|
Endoribonuclease and methods of use thereof
US Patent 9,688,971, 2017 View on Google Scholar ↗ |
2017 | 68 | 73.2% |
|
Type v crispr/cas effector proteins for cleaving ssdnas and detecting target dnas
US Patent App. 16/262,257, 2019 View on Google Scholar ↗ |
2019 | 51 | 73.1% |
|
Candidate phyla radiation roizmanbacteria from hot springs have novel and unexpectedly abundant CRISPR-Cas systems
Frontiers in microbiology 10, 928, 2019 View on Google Scholar ↗ |
2019 | 51 | 73.1% |
|
Programmable RNA recognition using a CRISPR-associated Argonaute
Proceedings of the National Academy of Sciences 115 (13), 3368-3373, 2018 View on Google Scholar ↗ |
2018 | 59 | 72.6% |
|
Stepwise DNA unwinding gates TnpB genome-editing activity
bioRxiv, 2026 View on Google Scholar ↗ |
2026 | 5 | 72.4% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 12,686,865, 2026 View on Google Scholar ↗ |
2026 | 5 | 72.4% |
|
CasZ compositions and methods of use
US Patent 11,180,743, 2021 View on Google Scholar ↗ |
2021 | 30 | 71.9% |
|
Methods and Compositions for detecting a target RNA
US Patent 11,459,599, 2022 View on Google Scholar ↗ |
2022 | 18 | 70.9% |
|
The stem-loop binding protein forms a highly stable and specific complex with the 3'stem-loop of histone mRNAs.
Rna 7 (1), 123-132, 2001 View on Google Scholar ↗ |
2001 | 108 | 70.8% |
|
The P4−P6 Domain Directs Higher Order Folding of the Tetrahymena Ribozyme Core
Biochemistry 36 (11), 3159-3169, 1997 View on Google Scholar ↗ |
1997 | 96 | 70.5% |
|
Ribozyme-catalyzed primer extension by trinucleotides: A model for the RNA-catalyzed replication of RNA
Biochemistry 32 (8), 2111-2115, 1993 View on Google Scholar ↗ |
1993 | 79 | 69.9% |
|
Functional overlap between eIF4G isoforms in Saccharomyces cerevisiae
PLoS one 5 (2), e9114, 2010 View on Google Scholar ↗ |
2010 | 89 | 69.7% |
|
Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone
MedRxiv, 2020.09. 28.20201947, 2020 View on Google Scholar ↗ |
2020 | 37 | 69.5% |
|
Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
bioRxiv, 2022.10. 19.512927, 2022 View on Google Scholar ↗ |
2022 | 17 | 69.5% |
|
Perspective: embryo editing needs scrutiny
Nature 528 (7580), S6-S6, 2015 View on Google Scholar ↗ |
2015 | 68 | 69.4% |
|
ATP-independent diffusion of double-stranded RNA binding proteins
Proceedings of the National Academy of Sciences 110 (1), 151-156, 2013 View on Google Scholar ↗ |
2013 | 75 | 69.3% |
|
Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies
Elife 5, e14663, 2016 View on Google Scholar ↗ |
2016 | 62 | 69.2% |
|
An essential GTPase promotes assembly of preribosomal RNA processing complexes
Molecular cell 20 (4), 633-643, 2005 View on Google Scholar ↗ |
2005 | 94 | 69.1% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 9,909,122, 2018 View on Google Scholar ↗ |
2018 | 51 | 69.0% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 10,125,361, 2018 View on Google Scholar ↗ |
2018 | 51 | 69.0% |
|
Genome-editing revolution: my whirlwind year with CRISPR
Nature 528 (7583), 469-471, 2015 View on Google Scholar ↗ |
2015 | 66 | 68.7% |
|
Miniribozymes, Small Derivatives of the sunY Intron, Are Catalytically Active
Molecular and cellular biology 9 (12), 5480-5483, 1989 View on Google Scholar ↗ |
1989 | 71 | 68.4% |
|
Casz compositions and methods of use
US Patent App. 16/694,720, 2020 View on Google Scholar ↗ |
2020 | 35 | 68.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,113,167, 2018 View on Google Scholar ↗ |
2018 | 48 | 67.5% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/947,680, 2018 View on Google Scholar ↗ |
2018 | 48 | 67.5% |
|
The phage nucleus synergizes with an anti-defense protein to resist bacterial immunity
Cell Reports 45 (4), 2026 View on Google Scholar ↗ |
2026 | 4 | 67.4% |
|
VIPR RNA-guided DNA recognition by noncontiguous geometric triplex formation
Science 393 (6817), 1236-1240, 2026 View on Google Scholar ↗ |
2026 | 4 | 67.4% |
|
Structural roles of monovalent cations in the HDV ribozyme
Structure 15 (3), 281-287, 2007 View on Google Scholar ↗ |
2007 | 84 | 67.3% |
|
Charpentier & Emmanuelle, The new frontier of genome engineering with CRISPR-Cas9
Science 346 (6213), 1258096, 2014 View on Google Scholar ↗ |
2014 | 66 | 67.2% |
|
CRISPR-Cas effector polypeptides and methods of use thereof
US Patent 11,578,313, 2023 View on Google Scholar ↗ |
2023 | 9 | 67.2% |
|
The P5abc Peripheral Element Facilitates Preorganization of the Tetrahymena Group I Ribozyme for Catalysis
Biochemistry 39 (10), 2639-2651, 2000 View on Google Scholar ↗ |
2000 | 92 | 67.1% |
|
Assembly of an exceptionally stable RNA tertiary interface in a group I ribozyme
Biochemistry 38 (10), 2982-2990, 1999 View on Google Scholar ↗ |
1999 | 83 | 66.8% |
|
A transcriptionally active lipid vesicle encloses the injected Chimalliviridae genome in early infection
bioRxiv, 2023.09. 20.558163, 2024 View on Google Scholar ↗ |
2024 | 7 | 66.6% |
|
Reporter nucleic acids for type v crispr-mediated detection
US Patent App. 17/270,215, 2021 View on Google Scholar ↗ |
2021 | 24 | 66.3% |
|
SRP RNA provides the physiologically essential GTPase activation function in cotranslational protein targeting
Rna 13 (2), 240-250, 2007 View on Google Scholar ↗ |
2007 | 79 | 66.0% |
|
The pathway of hepatitis C virus mRNA recruitment to the human ribosome
Nature structural & molecular biology 16 (4), 397-404, 2009 View on Google Scholar ↗ |
2009 | 76 | 66.0% |
|
Assembly of an active group II intron− maturase complex by protein dimerization
Biochemistry 43 (21), 6486-6497, 2004 View on Google Scholar ↗ |
2004 | 82 | 65.2% |
|
Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus
PLoS One 16 (5), e0251296, 2021 View on Google Scholar ↗ |
2021 | 23 | 65.2% |
|
Structural coordination between active sites of a CRISPR reverse transcriptase-integrase complex
Nature communications 12 (1), 2571, 2021 View on Google Scholar ↗ |
2021 | 23 | 65.2% |
|
Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing
The CRISPR Journal 3 (5), 332-349, 2020 View on Google Scholar ↗ |
2020 | 31 | 65.1% |
|
CRISPR-Cas12J effector polypeptides and methods of use thereof
US Patent 11,739,309, 2023 View on Google Scholar ↗ |
2023 | 8 | 64.5% |
|
CRISPR-Cas effector polypeptides and methods of use thereof
US Patent 11,685,909, 2023 View on Google Scholar ↗ |
2023 | 8 | 64.5% |
|
A functional mini-integrase in a two-protein type VC CRISPR system
Molecular cell 73 (4), 727-737. e3, 2019 View on Google Scholar ↗ |
2019 | 36 | 64.4% |
|
Compostions and methods of nucleic acid-targeting nucleic acids
US Patent 9,410,198, 2016 View on Google Scholar ↗ |
2016 | 51 | 64.4% |
|
Template-Directed Primer Extension Catalyzed by the Tetrahymena Ribozyme
Molecular and Cellular Biology 11 (6), 3390-3394, 1991 View on Google Scholar ↗ |
1991 | 58 | 64.0% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 9,725,714, 2017 View on Google Scholar ↗ |
2017 | 45 | 62.9% |
|
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples
PloS one 16 (8), e0255690, 2021 View on Google Scholar ↗ |
2021 | 21 | 62.8% |
|
Rapid, point-of-care molecular diagnostics with Cas13
MedRxiv, 2020.12. 14.20247874, 2021 View on Google Scholar ↗ |
2021 | 21 | 62.8% |
|
Methods and compositions for RNA-directed target DNA modification
US Patent 10,570,418, 2020 View on Google Scholar ↗ |
2020 | 28 | 62.4% |
|
New tools provide a second look at HDV ribozyme structure, dynamics and cleavage
Nucleic acids research 42 (20), 12833-12846, 2014 View on Google Scholar ↗ |
2014 | 54 | 62.1% |
|
The use of CRISPR/cas9, ZFNs, TALENs in generating site-specific genome alterations
Academic Press, 2014 View on Google Scholar ↗ |
2014 | 54 | 62.1% |
|
RNA seeing double: close-packing of helices in RNA tertiary structure
Trends in biochemical sciences 22 (7), 262-266, 1997 View on Google Scholar ↗ |
1997 | 64 | 62.1% |
|
Genomic engineering and the future of medicine
Jama 313 (8), 791-792, 2015 View on Google Scholar ↗ |
2015 | 49 | 61.1% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/749,599, 2016 View on Google Scholar ↗ |
2016 | 45 | 61.1% |
|
Rapid field-deployable detection of SARS-CoV-2 virus
US Patent 12,577,625, 2026 View on Google Scholar ↗ |
2026 | 3 | 61.0% |
|
CRISPR-Cas effector polypeptides and methods of use thereof
US Patent 11,530,398, 2022 View on Google Scholar ↗ |
2022 | 12 | 60.7% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/751,070, 2016 View on Google Scholar ↗ |
2016 | 44 | 60.5% |
|
CRISPR's unwanted anniversary
Science 366 (6467), 777-777, 2019 View on Google Scholar ↗ |
2019 | 31 | 60.5% |
|
Spacer acquisition rates determine the immunological diversity of the type II CRISPR-Cas immune response
Cell host & microbe 25 (2), 242-249. e3, 2019 View on Google Scholar ↗ |
2019 | 31 | 60.5% |
|
Chemical synthesis of oligoribonucleotides containing 2-aminopurine: substrates for the investigation of ribozyme function
The Journal of organic chemistry 55 (21), 5547-5549, 1990 View on Google Scholar ↗ |
1990 | 48 | 60.0% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/751,058, 2016 View on Google Scholar ↗ |
2016 | 42 | 59.2% |
|
Methods and compositions for modifying a single stranded target nucleic acid
US Patent 9,994,831, 2018 View on Google Scholar ↗ |
2018 | 34 | 58.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/825,807, 2020 View on Google Scholar ↗ |
2020 | 24 | 58.4% |
|
Eingriff in die Evolution: Die Macht der CRISPR-Technologie und die Frage, wie wir sie nutzen wollen
Springer, 2018 View on Google Scholar ↗ |
2018 | 33 | 58.0% |
|
GTP-dependent formation of a ribonucleoprotein subcomplex required for ribosome biogenesis
Journal of molecular biology 356 (2), 432-443, 2006 View on Google Scholar ↗ |
2006 | 55 | 57.7% |
|
Compositions and methods for delivering crispr/cas effector polypeptides
US Patent App. 17/287,392, 2023 View on Google Scholar ↗ |
2023 | 6 | 57.4% |
|
RNA-mediated interaction between the peptide-binding and GTPase domains of the signal recognition particle
Nature structural & molecular biology 12 (12), 1116-1122, 2005 View on Google Scholar ↗ |
2005 | 54 | 57.4% |
|
On human gene editing: International summit statement
Washington DC: National Academy of Sciences, 2015 View on Google Scholar ↗ |
2015 | 42 | 57.2% |
|
Sensitive and multiplexed RNA detection with Cas13 droplets and kinetic barcoding
MedRXiv, 2021.08. 02.21261509, 2021 View on Google Scholar ↗ |
2021 | 17 | 57.1% |
|
Emerging themes in RNA folding
Folding and Design 2 (5), R65-R70, 1997 View on Google Scholar ↗ |
1997 | 50 | 57.0% |
|
A miniature CRISPR-Cas10 enzyme confers immunity by an inverse signaling pathway
bioRxiv, 2025.03. 28.646030, 2025 View on Google Scholar ↗ |
2025 | 4 | 56.3% |
|
CRISPR-Cas effector polypeptides and methods of use thereof
US Patent 12,365,887, 2025 View on Google Scholar ↗ |
2025 | 4 | 56.3% |
|
RNA structure: crystal clear?
Current Opinion in Structural Biology 7 (3), 310-316, 1997 View on Google Scholar ↗ |
1997 | 48 | 56.3% |
|
Structural and energetic analysis of metal ions essential to SRP signal recognition domain assembly
Biochemistry 41 (39), 11703-11710, 2002 View on Google Scholar ↗ |
2002 | 51 | 55.7% |
|
Crystal structure of an RNA/DNA strand exchange junction
Plos one 17 (4), e0263547, 2022 View on Google Scholar ↗ |
2022 | 10 | 55.7% |
|
Cas9 variants and methods of use thereof
US Patent 10,392,607, 2019 View on Google Scholar ↗ |
2019 | 25 | 54.6% |
|
Evolutionarily conserved roles of the dicer helicase domain in regulating RNA interference processing
Journal of Biological Chemistry 289 (41), 28352-28362, 2014 View on Google Scholar ↗ |
2014 | 39 | 53.9% |
|
Nucleic acid aptamers in therapeutic anticoagulation
Thrombosis and haemostasis 93 (06), 1014-1020, 2005 View on Google Scholar ↗ |
2005 | 45 | 53.6% |
|
Diverse ATPase proteins in mobilomes constitute a large potential sink for prokaryotic host ATP
Frontiers in Microbiology 12, 691847, 2021 View on Google Scholar ↗ |
2021 | 15 | 53.6% |
|
Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
Emerging Microbes & Infections 12 (2), 2270071, 2023 View on Google Scholar ↗ |
2023 | 5 | 52.8% |
|
RNA-guided nucleic acid modifying enzymes and methods of use thereof
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States), 2023 View on Google Scholar ↗ |
2023 | 5 | 52.8% |
|
RNA-targeting CRISPR-Cas13 provides broad-spectrum phage immunity
bioRxiv, 2022.03. 25.485874, 2022 View on Google Scholar ↗ |
2022 | 9 | 52.7% |
|
Structural and biochemical studies of a fluoroacetyl-CoA-specific thioesterase reveal a molecular basis for fluorine selectivity
Biochemistry 49 (43), 9269, 2010 View on Google Scholar ↗ |
2010 | 42 | 52.7% |
|
Preparation of homogeneous ribozyme RNA for crystallization
Ribozyme protocols, 365-370, 1997 View on Google Scholar ↗ |
1997 | 38 | 51.8% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,415,061, 2019 View on Google Scholar ↗ |
2019 | 22 | 51.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,308,961, 2019 View on Google Scholar ↗ |
2019 | 22 | 51.3% |
|
Identification and analysis of U5 snRNA variants in Drosophila
Rna 11 (10), 1473-1477, 2005 View on Google Scholar ↗ |
2005 | 40 | 51.3% |
|
A host of factors regulating influenza virus replication
Viruses 2 (2), 566-573, 2010 View on Google Scholar ↗ |
2010 | 39 | 51.1% |
|
Distinct contributions of KH domains to substrate binding affinity of Drosophila P-element somatic inhibitor protein
Rna 12 (2), 283-291, 2006 View on Google Scholar ↗ |
2006 | 40 | 51.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent App. 15/981,809, 2018 View on Google Scholar ↗ |
2018 | 25 | 50.6% |
|
Harmonizing standards and resources for the medical genome
Nature 655 (8121), 47-58, 2026 View on Google Scholar ↗ |
2026 | 2 | 50.2% |
|
Methods for detecting and sequencing a target nucleic acid
US Patent 12,644,145, 2026 View on Google Scholar ↗ |
2026 | 2 | 50.2% |
|
Spligation enables programmable chimeric RNA generation in living cells
bioRxiv, 2026 View on Google Scholar ↗ |
2026 | 2 | 50.2% |
|
A noncontiguous code for RNA-guided DNA recognition preceded CRISPR
bioRxiv, 2026 View on Google Scholar ↗ |
2026 | 2 | 50.2% |
|
Compositions and methods for targeted delivery of CRISPR-Cas effector polypeptides
US Patent App. 19/103,517, 2026 View on Google Scholar ↗ |
2026 | 2 | 50.2% |
|
Phage-based microbiome manipulation elucidates interactions within community context
bioRxiv, 2025.06. 20.660599, 2025 View on Google Scholar ↗ |
2025 | 3 | 50.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,421,980, 2019 View on Google Scholar ↗ |
2019 | 21 | 50.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,519,467, 2019 View on Google Scholar ↗ |
2019 | 21 | 50.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,385,360, 2019 View on Google Scholar ↗ |
2019 | 21 | 50.1% |
|
Methods to crystallize RNA
Current protocols in nucleic acid chemistry 1 (1), 7.6. 1-7.6. 13, 2000 View on Google Scholar ↗ |
2000 | 37 | 49.6% |
|
Borgs are giant extrachromosomal elements with the potential to augment methane oxidation
BioRxiv, 2021.07. 10.451761, 2021 View on Google Scholar ↗ |
2021 | 13 | 49.6% |
|
Modified cells comprising CRISPR systems
US Patent 11,377,646, 2022 View on Google Scholar ↗ |
2022 | 8 | 49.6% |
|
Tissue-specific genome engineering using CRISPR-Cas9
US Patent 10,851,367, 2020 View on Google Scholar ↗ |
2020 | 17 | 49.1% |
|
Hammerhead ribozyme structure: U-turn for RNA structural biology
Structure 3 (8), 747-750, 1995 View on Google Scholar ↗ |
1995 | 30 | 49.1% |
|
Genome editing: the end of the beginning
Genome biology 16 (1), 292, 2015 View on Google Scholar ↗ |
2015 | 30 | 48.6% |
|
Tertiäre Motive bei Struktur und Faltung von RNA
Angewandte Chemie 111 (16), 2472-2491, 1999 View on Google Scholar ↗ |
1999 | 33 | 48.6% |
|
The parallel universe of RNA folding
nature structural biology 5 (5), 337-340, 1998 View on Google Scholar ↗ |
1998 | 32 | 48.6% |
|
A fast and efficient procedure to produce scFvs specific for large macromolecular complexes
Journal of immunological methods 318 (1-2), 95-101, 2007 View on Google Scholar ↗ |
2007 | 35 | 48.4% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent App. 14/751,088, 2016 View on Google Scholar ↗ |
2016 | 27 | 47.7% |
|
Una grieta en la creación
Alianza editorial, 2020 View on Google Scholar ↗ |
2020 | 16 | 47.5% |
|
Toph (true retrieval of proteins homologs): Adapting a contrastive question-answering framework for protein search
ICML workshop on computational biology, 2023 View on Google Scholar ↗ |
2023 | 4 | 47.4% |
|
Genomic analysis of cultivated infant microbiomes identifies Bifidobacterium 2’-fucosyllactose utilization can be facilitated by co-existing species
bioRxiv, 2023.03. 10.532136, 2023 View on Google Scholar ↗ |
2023 | 4 | 47.4% |
|
Methods and compositions for labeling a single-stranded target nucleic acid
US Patent 11,180,792, 2021 View on Google Scholar ↗ |
2021 | 12 | 47.4% |
|
Compositions and methods of nucleic acid-targeting nucleic acids
US Patent 9,809,814, 2017 View on Google Scholar ↗ |
2017 | 24 | 47.1% |
|
[12] Solving large RNA structures by X-ray crystallography
Academic Press 317, 169-180, 2000 View on Google Scholar ↗ |
2000 | 32 | 47.0% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/915,020, 2019 View on Google Scholar ↗ |
2019 | 18 | 46.1% |
|
Cell type-programmable genome editing with enveloped delivery vehicles
Biorxiv, 505004, 2022 View on Google Scholar ↗ |
2022 | 7 | 46.0% |
|
Genetic dissection of an RNA enzyme
Cold Spring Harbor symposia on quantitative biology 52, 173-180, 1987 View on Google Scholar ↗ |
1987 | 22 | 46.0% |
|
Methods and compositions for detecting a target rna
US Patent App. 18/492,550, 2024 View on Google Scholar ↗ |
2024 | 3 | 45.8% |
|
Class 2 crispr/cas compositions and methods of use
US Patent App. 18/618,668, 2024 View on Google Scholar ↗ |
2024 | 3 | 45.8% |
|
The CRISPR revolution: can we change genes for the better
Frontiers for Young Minds 12, 1063878, 2024 View on Google Scholar ↗ |
2024 | 3 | 45.8% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,970,711, 2024 View on Google Scholar ↗ |
2024 | 3 | 45.8% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 18/313,914, 2024 View on Google Scholar ↗ |
2024 | 3 | 45.8% |
|
Rna-guided nucleic acid modifying enzymes and methods of use thereof
US Patent App. 17/258,047, 2021 View on Google Scholar ↗ |
2021 | 11 | 45.1% |
|
Mechanisms of internal ribosome entry in translation initiation
Cold Spring Harbor symposia on quantitative biology 66, 277-284, 2001 View on Google Scholar ↗ |
2001 | 27 | 44.8% |
|
Knocking out barriers to engineered cell activity
Science 367 (6481), 976-977, 2020 View on Google Scholar ↗ |
2020 | 14 | 44.0% |
|
CRISPR-Cas: a laboratory manual
(No Title), 2016 View on Google Scholar ↗ |
2016 | 23 | 43.9% |
|
Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules
Rna 19 (12), 1825-1832, 2013 View on Google Scholar ↗ |
2013 | 26 | 43.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/981,808, 2018 View on Google Scholar ↗ |
2018 | 19 | 43.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/981,807, 2018 View on Google Scholar ↗ |
2018 | 19 | 43.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/947,700, 2018 View on Google Scholar ↗ |
2018 | 19 | 43.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/947,718, 2018 View on Google Scholar ↗ |
2018 | 19 | 43.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,351,878, 2019 View on Google Scholar ↗ |
2019 | 16 | 43.3% |
|
CRISPR-CasX is an RNA-dominated enzyme active for human genome editing
Nature 566 (7743), 218, 2019 View on Google Scholar ↗ |
2019 | 16 | 43.3% |
|
Analog sensitive chemical inhibition of the DEAD‐box protein DDX 3
Protein Science 25 (3), 638-649, 2016 View on Google Scholar ↗ |
2016 | 22 | 42.9% |
|
Modified site-directed modifying polypeptides and methods of use thereof
US Patent 11,118,194, 2021 View on Google Scholar ↗ |
2021 | 10 | 42.5% |
|
LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples
PLoS One 16 (11), e0258263, 2021 View on Google Scholar ↗ |
2021 | 10 | 42.5% |
|
Science273, 1678− 1685
There is no corresponding record for this reference, 1996 View on Google Scholar ↗ |
1996 | 20 | 42.2% |
|
An unusual case of pseudo-merohedral twinning in orthorhombic crystals of Dicer
Biological Crystallography 63 (9), 993-999, 2007 View on Google Scholar ↗ |
2007 | 25 | 42.1% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/965,603, 2018 View on Google Scholar ↗ |
2018 | 17 | 41.2% |
|
CRISPR and gene editing: ethical and scientific perspectives
International Journal of Innovative Computer Science and IT Research 1 (01 …, 2025 View on Google Scholar ↗ |
2025 | 2 | 41.0% |
|
To TnpB or not TnpB? Cas12 is the answer
Nature chemical biology 19 (3), 263-264, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 18/345,507, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Casz compositions and methods of use
US Patent App. 17/935,521, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,549,127, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 17/990,074, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA. 1 variant through NSP6. bioRxiv. 2023
Epub 2023/02/18. https://doi. org/10.1101/2023.01. 31.525914 PMID: 36798416, 0 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 18/021,469, 2023 View on Google Scholar ↗ |
2023 | 3 | 40.7% |
|
Rapid detection of SARS-CoV-2 with Cas13
medRxiv 10 (2020.12), 14, 2020 View on Google Scholar ↗ |
2020 | 12 | 40.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,358,658, 2019 View on Google Scholar ↗ |
2019 | 14 | 40.1% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,337,029, 2019 View on Google Scholar ↗ |
2019 | 14 | 40.1% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/959,735, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/959,715, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/959,782, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/959,802, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/965,598, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 15/959,762, 2018 View on Google Scholar ↗ |
2018 | 16 | 39.8% |
|
Chemical biology at the crossroads of molecular structure and mechanism
Nature Chemical Biology 1 (6), 300-303, 2005 View on Google Scholar ↗ |
2005 | 20 | 39.0% |
|
Conserved but nonessential interaction of SRP RNA with translation factor EF-G
Rna 10 (5), 772-778, 2004 View on Google Scholar ↗ |
2004 | 20 | 38.9% |
|
Ribozymes: The hammerhead swings into action
Current biology 8 (14), R495-R497, 1998 View on Google Scholar ↗ |
1998 | 18 | 38.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,443,076, 2019 View on Google Scholar ↗ |
2019 | 13 | 38.4% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,358,659, 2019 View on Google Scholar ↗ |
2019 | 13 | 38.4% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,428,352, 2019 View on Google Scholar ↗ |
2019 | 13 | 38.4% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,669,560, 2020 View on Google Scholar ↗ |
2020 | 11 | 38.2% |
|
Huge and variable diversity of episymbiotic CPR bacteria and DPANN archaea in groundwater ecosystems
bioRxiv, 2020.05. 14.094862, 2020 View on Google Scholar ↗ |
2020 | 11 | 38.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,676,759, 2020 View on Google Scholar ↗ |
2020 | 11 | 38.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,626,419, 2020 View on Google Scholar ↗ |
2020 | 11 | 38.2% |
|
Distinct sites of phosphorothioate substitution interfere with folding and splicing of the Anabaena group I intron
Nucleic acids research 32 (7), 2272-2280, 2004 View on Google Scholar ↗ |
2004 | 19 | 38.1% |
|
The new frontier of genome engineering with CRISPR-Cas9
Science 346 (6213), 1077-1088, 2014 View on Google Scholar ↗ |
2014 | 19 | 37.9% |
|
On human gene editing: international summit statement by the organizing committee
Issues in Science and Technology 32 (3), 55-57, 2016 View on Google Scholar ↗ |
2016 | 17 | 37.4% |
|
A phosphoramidate substrate analog is a competitive inhibitor of the Tetrahymena group I ribozyme
Chemistry & Biology 7 (11), 845-854, 2000 View on Google Scholar ↗ |
2000 | 17 | 37.0% |
|
Heritable genome editing using TALENs and CRISPR/Cas9 to engineer precise insertions and deletions in evolutionarily diverse nematode species
Genetics 195 (2), 331-348, 2013 View on Google Scholar ↗ |
2013 | 18 | 36.6% |
|
RNA scanning of a molecular machine with a built-in ruler
Journal of the American Chemical Society 139 (1), 262-268, 2017 View on Google Scholar ↗ |
2017 | 15 | 36.5% |
|
Spatiotemporal photocatalytic proximity labeling proteomics reveals ligand-activated extracellular and intracellular EGFR neighborhoods
bioRxiv, 2024.12. 21.629933, 2024 View on Google Scholar ↗ |
2024 | 2 | 36.0% |
|
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Biophysical Journal 114 (3), 194a, 2018 View on Google Scholar ↗ |
2018 | 13 | 35.3% |
|
Establishing Suitability of RNA Preparations for Crystallization: Determination of Polydispersity
Ribozyme Protocols, 371-377, 1997 View on Google Scholar ↗ |
1997 | 14 | 35.3% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/136,168, 2019 View on Google Scholar ↗ |
2019 | 11 | 34.9% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/136,175, 2019 View on Google Scholar ↗ |
2019 | 11 | 34.9% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/136,159, 2019 View on Google Scholar ↗ |
2019 | 11 | 34.9% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/136,165, 2019 View on Google Scholar ↗ |
2019 | 11 | 34.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,752,920, 2020 View on Google Scholar ↗ |
2020 | 9 | 33.7% |
|
Crispr2vec: machine learning model predicts off-target cuts of crispr systems
BioRxiv, 2020.10. 28.359885, 2020 View on Google Scholar ↗ |
2020 | 9 | 33.7% |
|
Protein delivery in primary hematopoietic cells
2016 View on Google Scholar ↗ |
2016 | 14 | 33.6% |
|
Compositions and methods for modification of target molecules
US Patent 12,624,063, 2026 View on Google Scholar ↗ |
2026 | 1 | 33.1% |
|
Amplified genome editing by in vivo editor production
bioRxiv, 2026 View on Google Scholar ↗ |
2026 | 1 | 33.1% |
|
Reprogramming Cas9 PAM Recognition for Allele-Specific Editing
bioRxiv, 2026.08. 10.744034, 2026 View on Google Scholar ↗ |
2026 | 1 | 33.1% |
|
Triplex formation drives noncontiguous VIPR RNA-guided DNA recognition
bioRxiv, 2026.04. 26.720927, 2026 View on Google Scholar ↗ |
2026 | 1 | 33.1% |
|
Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,400,253, 2019 View on Google Scholar ↗ |
2019 | 10 | 33.0% |
|
Guided Tour to the Heart of RISC
Science 336 (6084), 985-986, 2012 View on Google Scholar ↗ |
2012 | 15 | 32.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,473,108, 2022 View on Google Scholar ↗ |
2022 | 4 | 32.5% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 17/514,936, 2022 View on Google Scholar ↗ |
2022 | 4 | 32.5% |
|
Optimized high-throughput screen for hepatitis C virus translation inhibitors
Journal of biomolecular screening 16 (2), 211-220, 2011 View on Google Scholar ↗ |
2011 | 14 | 32.5% |
|
SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation (reviewed preprint)
Cell Host Microbe. doi 10, 2023 View on Google Scholar ↗ |
2023 | 2 | 31.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,634,730, 2023 View on Google Scholar ↗ |
2023 | 2 | 31.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,814,645, 2023 View on Google Scholar ↗ |
2023 | 2 | 31.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,674,159, 2023 View on Google Scholar ↗ |
2023 | 2 | 31.7% |
|
A sparse matrix approach to crystallizing ribozymes and RNA motifs
Ribozyme protocols, 379-386, 1997 View on Google Scholar ↗ |
1997 | 11 | 31.6% |
|
Protein–nucleic acid interactions
Current Opinion in Structural Biology 11 (1), 11-13, 2001 View on Google Scholar ↗ |
2001 | 11 | 31.5% |
|
Protein–nucleic acid interactions
Current opinion in structural biology 13 (1), 3, 2003 View on Google Scholar ↗ |
2003 | 11 | 31.1% |
|
Method of producing dicer
US Patent 9,434,930, 2016 View on Google Scholar ↗ |
2016 | 12 | 30.9% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 17/225,866, 2021 View on Google Scholar ↗ |
2021 | 6 | 30.5% |
|
Endoribonuclease compositions and methods of use thereof
US Patent 9,605,246, 2017 View on Google Scholar ↗ |
2017 | 10 | 29.0% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,526,619, 2020 View on Google Scholar ↗ |
2020 | 7 | 28.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,793,878, 2020 View on Google Scholar ↗ |
2020 | 7 | 28.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,550,407, 2020 View on Google Scholar ↗ |
2020 | 7 | 28.7% |
|
Compositions and Methods of Nucleic Acid-Targeting Nucleic Acids
US Patent App. 15/904,285, 2018 View on Google Scholar ↗ |
2018 | 9 | 28.5% |
|
Reporter cas9 variants and methods of use thereof
US Patent App. 15/574,748, 2018 View on Google Scholar ↗ |
2018 | 9 | 28.5% |
|
Quantitative studies of ribosome conformational dynamics
Quarterly Reviews of Biophysics 40 (2), 163-189, 2007 View on Google Scholar ↗ |
2007 | 10 | 28.2% |
|
Voices of biotech
Nature biotechnology 34 (3), 270-275, 2016 View on Google Scholar ↗ |
2016 | 10 | 27.9% |
|
A crack in creation: gene editing and the unthinkable power to control evolution
The Humanist 77 (6), 42-43, 2017 View on Google Scholar ↗ |
2017 | 9 | 27.3% |
|
Creative catalysis: pieces of the RNA world jigsaw
Trends in Biochemical Sciences 26 (12), 699-701, 2001 View on Google Scholar ↗ |
2001 | 8 | 27.2% |
|
A molecular contortionist
Nature 388 (6645), 830-831, 1997 View on Google Scholar ↗ |
1997 | 8 | 27.1% |
|
Native tandem and ion mobility mass spectrometry highlight structural and modular similarities in Clustered-Regularly-Interspaced Shot-Palindromic-Repeats (CRISPR)-associated …
Mol. Cell. Proteomics 11, 1430-1441, 2012 View on Google Scholar ↗ |
2012 | 10 | 27.0% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,900,054, 2021 View on Google Scholar ↗ |
2021 | 5 | 26.8% |
|
Methods and kits for identifying cancer treatment targets
US Patent App. 17/284,660, 2021 View on Google Scholar ↗ |
2021 | 5 | 26.8% |
|
Mutational scanning of TnpB reveals latent activity for genome editing
bioRxiv, 2025 View on Google Scholar ↗ |
2025 | 1 | 26.7% |
|
In Vivo Generation of TRAC-Targeted CAR T Cells via Site-Specific Integration Enables Cell-Specific Engineering and Potent Antitumor Activity
MOLECULAR THERAPY 33 (4), 2025 View on Google Scholar ↗ |
2025 | 1 | 26.7% |
|
Methods and kits for identifying cancer treatment targets
US Patent 12,270,027, 2025 View on Google Scholar ↗ |
2025 | 1 | 26.7% |
|
Expanding the chemical diversity of DNA
Synlett 29 (11), 1405-1414, 2018 View on Google Scholar ↗ |
2018 | 8 | 26.7% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,487,341, 2019 View on Google Scholar ↗ |
2019 | 7 | 26.6% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,274,318, 2022 View on Google Scholar ↗ |
2022 | 3 | 26.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,293,034, 2022 View on Google Scholar ↗ |
2022 | 3 | 26.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,401,532, 2022 View on Google Scholar ↗ |
2022 | 3 | 26.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,332,761, 2022 View on Google Scholar ↗ |
2022 | 3 | 26.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,242,543, 2022 View on Google Scholar ↗ |
2022 | 3 | 26.5% |
|
Cas12c compositions and methods of use
US Patent App. 16/757,981, 2020 View on Google Scholar ↗ |
2020 | 6 | 25.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,577,631, 2020 View on Google Scholar ↗ |
2020 | 6 | 25.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,612,045, 2020 View on Google Scholar ↗ |
2020 | 6 | 25.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,563,227, 2020 View on Google Scholar ↗ |
2020 | 6 | 25.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,597,680, 2020 View on Google Scholar ↗ |
2020 | 6 | 25.9% |
|
Ro’s role in RNA reconnaissance
Cell 121 (4), 495-496, 2005 View on Google Scholar ↗ |
2005 | 7 | 24.8% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/276,365, 2019 View on Google Scholar ↗ |
2019 | 6 | 24.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,513,712, 2019 View on Google Scholar ↗ |
2019 | 6 | 24.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,186,849, 2021 View on Google Scholar ↗ |
2021 | 4 | 22.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,008,590, 2021 View on Google Scholar ↗ |
2021 | 4 | 22.9% |
|
Crispr-cas effector polypeptides and methods of use thereof
US Patent App. 17/308,572, 2021 View on Google Scholar ↗ |
2021 | 4 | 22.9% |
|
IGI-LuNER: single-well multiplexed RT-qPCR test for SARS-CoV-2
medRxiv, 2020 View on Google Scholar ↗ |
2020 | 5 | 22.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,533,190, 2020 View on Google Scholar ↗ |
2020 | 5 | 22.9% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,640,791, 2020 View on Google Scholar ↗ |
2020 | 5 | 22.9% |
|
The Nobel Prize in Chemistry 2020
Press Release, 2020 View on Google Scholar ↗ |
2020 | 5 | 22.9% |
|
Engineered CRISPR-Cas9 Nucleases
US Patent App. 16/620,367, 2020 View on Google Scholar ↗ |
2020 | 5 | 22.9% |
|
Get in LINE: competition for newly minted retrotransposon proteins at the ribosome
Molecular cell 60 (5), 712-714, 2015 View on Google Scholar ↗ |
2015 | 7 | 22.4% |
|
Mutant proteinase with reduced self-cleavage activity and method of purification
US Patent 7,494,786, 2009 View on Google Scholar ↗ |
2009 | 6 | 22.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 12,123,015, 2024 View on Google Scholar ↗ |
2024 | 1 | 22.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 12,180,504, 2024 View on Google Scholar ↗ |
2024 | 1 | 22.3% |
|
Compositions and methods for modifying rna
US Patent App. 18/338,150, 2024 View on Google Scholar ↗ |
2024 | 1 | 22.3% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 12,180,503, 2024 View on Google Scholar ↗ |
2024 | 1 | 22.3% |
|
Reply to Nathamgari et al.: nanopore electroporation for intracellular delivery of biological macromolecules
Proceedings of the National Academy of Sciences 116 (46), 22911-22911, 2019 View on Google Scholar ↗ |
2019 | 5 | 21.7% |
|
Methods and compositions for modifying a single stranded target nucleic acid
US Patent 10,494,620, 2019 View on Google Scholar ↗ |
2019 | 5 | 21.7% |
|
How will kinetics and thermodynamics inform our future efforts to understand and build biological systems?
Cell Systems 4 (2), 144-146, 2017 View on Google Scholar ↗ |
2017 | 6 | 21.6% |
|
Ribosomes: Cashing in on crystals
Current biology 9 (19), R731-R734, 1999 View on Google Scholar ↗ |
1999 | 5 | 21.0% |
|
5 Catalytic Strategies of Self-Cleaving Ribozymes: Relics of an RNA World?
Cold Spring Harbor Monograph Archive 43, 109-131, 2006 View on Google Scholar ↗ |
2006 | 5 | 20.6% |
|
RNAs regulate biology
ACS chemical biology 1 (6), 335-338, 2006 View on Google Scholar ↗ |
2006 | 5 | 20.6% |
|
The new frontier of genome engineering 294 with CRISPR-Cas9
Science 346 (1258096), 295, 2014 View on Google Scholar ↗ |
2014 | 6 | 20.5% |
|
A Crack in Creation: Gene Editing and the Unthinkable Power Tocontrol Evolution
Mariner Books, 2018 View on Google Scholar ↗ |
2018 | 5 | 20.2% |
|
Mass spectrometry special feature: mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3
Proceedings of the National Academy of Science 105 (47), 18139-18144, 2008 View on Google Scholar ↗ |
2008 | 5 | 19.9% |
|
CRISPR's second decade: jennifer doudna looks forward and back
GEN Biotechnology 1 (5), 415-420, 2022 View on Google Scholar ↗ |
2022 | 2 | 19.7% |
|
Methods and kits for identifying cancer treatment targets
US Patent App. 17/717,594, 2022 View on Google Scholar ↗ |
2022 | 2 | 19.7% |
|
Blueprint for a pop-up SARS-CoV-2 testing lab
medRxiv, 2020 View on Google Scholar ↗ |
2020 | 4 | 19.6% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,774,344, 2020 View on Google Scholar ↗ |
2020 | 4 | 19.6% |
|
Thermostable RNA-guided endonucleases and methods of use thereof
US Patent 11,692,184, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
Assembly reactions of SARS-CoV-2 nucleocapsid protein with nucleic acid
bioRxiv, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
Transposon systems for genome editing
US Patent App. 17/794,166, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
Compositions and methods for increasing homology-directed repair
US Patent App. 18/014,700, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
CRISPR-Cas based system for targeting single-stranded sequences
US Patent 11,661,599, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
Activators of type iii cas proteins
US Patent App. 18/245,183, 2023 View on Google Scholar ↗ |
2023 | 1 | 19.5% |
|
Variant Cas9 polypeptides comprising internal insertions
US Patent 11,008,555, 2021 View on Google Scholar ↗ |
2021 | 3 | 18.6% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,008,589, 2021 View on Google Scholar ↗ |
2021 | 3 | 18.6% |
|
Hiv or hcv detection with crispr-cas13a
US Patent App. 17/273,752, 2021 View on Google Scholar ↗ |
2021 | 3 | 18.6% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,001,863, 2021 View on Google Scholar ↗ |
2021 | 3 | 18.6% |
|
Rational design of a split-Cas9 enzyme complex
Proc Natl Acad Sci USA, 2015 View on Google Scholar ↗ |
2015 | 5 | 18.6% |
|
Hammering out the shape of a ribozyme
Structure 2 (12), 1271-1272, 1994 View on Google Scholar ↗ |
1994 | 4 | 18.2% |
|
Crystal Structure of a Group I Ribozyme Domain Reveals New Principles of RNA Folding
Protein Engineering 10, 41-41, 1997 View on Google Scholar ↗ |
1997 | 4 | 18.1% |
|
Yaratılıştaki çatlak: gen düzenlemenin evrime hükmeden inanılmaz gücü
Koç Üniversitesi, 2018 View on Google Scholar ↗ |
2018 | 4 | 17.5% |
|
Inhibitory activity restricts the function of an avian-like influenza polymerase in primate cells
Cell host & microbe 4 (2), 111, 2008 View on Google Scholar ↗ |
2008 | 4 | 17.5% |
|
Nucleic acids and their protein partners
Current Opinion in Structural Biology 18 (3), 279-281, 2008 View on Google Scholar ↗ |
2008 | 4 | 17.5% |
|
Correction for Wiedenheft et al., RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions
Proceedings of the National Academy of Sciences of the United States of …, 2011 View on Google Scholar ↗ |
2011 | 4 | 17.1% |
|
Rewriting the Code of Life.
National Catholic Bioethics Quarterly 17 (1), 37, 2017 View on Google Scholar ↗ |
2017 | 4 | 17.1% |
|
CRISPR system: from adaptive immunity to genome editing
Molecular Frontiers Journal 1 (02), 76-91, 2017 View on Google Scholar ↗ |
2017 | 4 | 17.1% |
|
Compositions and methods for enhancing genome editing
US Patent App. 16/628,114, 2020 View on Google Scholar ↗ |
2020 | 3 | 16.2% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,570,419, 2020 View on Google Scholar ↗ |
2020 | 3 | 16.2% |
|
Specific detection of ribonucleic acid sequences using novel crispr enzyme-mediated detection strategies
US Patent App. 16/049,457, 2020 View on Google Scholar ↗ |
2020 | 3 | 16.2% |
|
Erratum: The stem-loop binding protein forms a highly stable and specific complex with the 3′ stem-loop of histone mRNAs (RNA 7: 1 (123-132))
RNA 7 (4), 642-643, 2001 View on Google Scholar ↗ |
2001 | 3 | 15.7% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/276,374, 2019 View on Google Scholar ↗ |
2019 | 3 | 15.6% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/276,368, 2019 View on Google Scholar ↗ |
2019 | 3 | 15.6% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/276,361, 2019 View on Google Scholar ↗ |
2019 | 3 | 15.6% |
|
Molecular mechanism of off-target effects in CRISPR-Cas9
BiorXiv, 421537, 2018 View on Google Scholar ↗ |
2018 | 3 | 14.6% |
|
Correction: RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System
Plos one 12 (4), e0175612, 2017 View on Google Scholar ↗ |
2017 | 3 | 14.3% |
|
A Crack in Creation Gene Editing
Boston, MA, USA: Mariner Books, 2017 View on Google Scholar ↗ |
2017 | 3 | 14.3% |
|
Modified dicer polypeptide and methods of use thereof
US Patent 8,440,430, 2013 View on Google Scholar ↗ |
2013 | 3 | 14.0% |
|
Activating silent argonautes
Nature Structural & Molecular Biology 20 (7), 769-771, 2013 View on Google Scholar ↗ |
2013 | 3 | 14.0% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,982,231, 2021 View on Google Scholar ↗ |
2021 | 2 | 13.8% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,988,782, 2021 View on Google Scholar ↗ |
2021 | 2 | 13.8% |
|
Corrigendum to" Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery" Acta Biomaterialia (2020), 114, 358-368
Acta biomaterialia 121, 764, 2021 View on Google Scholar ↗ |
2021 | 2 | 13.8% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,982,230, 2021 View on Google Scholar ↗ |
2021 | 2 | 13.8% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 10,988,780, 2021 View on Google Scholar ↗ |
2021 | 2 | 13.8% |
|
The Chemistry of CRISPR: Editing the Code of Life/CRISPR-Cas9: Biology and Technology of Genome Editing
Nobel Lecture, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
A tool for genome editing
Nobel prize in Chemistry, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
Attachment of a 32P-phosphate to the 3′ Terminus of a DNA Oligonucleotide
Bio-protocol 10 (20), e3787-e3787, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
Methods and compositions for modifying a single stranded target nucleic acid
US Patent App. 16/698,276, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
Cas9 variants and methods of use thereof
US Patent 10,793,842, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
Blueprint for a pop-up SARS-CoV-2 testing lab
medRxiv, 2020.04. 11.20061424, 2020 View on Google Scholar ↗ |
2020 | 2 | 12.1% |
|
RNA Structures Determined by X-ray Crystallography
RNA 6, 04, 2001 View on Google Scholar ↗ |
2001 | 2 | 12.1% |
|
Preliminary X-ray diffraction studies of an RNA pseudoknot that inhibits HIV-1 reverse transcriptase
Biological Crystallography 52 (5), 1018-1020, 1996 View on Google Scholar ↗ |
1996 | 2 | 12.0% |
|
Molecular mechanism of off-target effects in CRISPR-Cas9
Biophysical Journal 116 (3), 319a, 2019 View on Google Scholar ↗ |
2019 | 2 | 12.0% |
|
Mutant proteinase with reduced self-cleavage activity and method of purification
US Patent App. 12/184,315, 2008 View on Google Scholar ↗ |
2008 | 2 | 11.5% |
|
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US Patent 11,479,794, 2022 View on Google Scholar ↗ |
2022 | 1 | 11.3% |
|
Towards the design of an RNA replicase
Harvard University, 1989 View on Google Scholar ↗ |
1989 | 2 | 11.2% |
|
METHODS IN ENZYMOLOGY PREFACE
USE OF CRISPR/CAS9, ZFNS, AND TALENS IN GENERATING SITE-SPECIFIC GENOME …, 2014 View on Google Scholar ↗ |
2014 | 2 | 10.6% |
|
Real-time observation of DNA recognition by the RNA-guided endonuclease Cas9 using single-molecule FRET
Biophysical Journal 108 (2), 26a, 2015 View on Google Scholar ↗ |
2015 | 2 | 10.6% |
|
Proteins that inhibit cas12a (cpf1), a cripr-cas nuclease
US Patent App. 17/252,947, 2021 View on Google Scholar ↗ |
2021 | 1 | 8.0% |
|
Variant RNA-guided polypeptides and methods of use
US Patent 11,180,778, 2021 View on Google Scholar ↗ |
2021 | 1 | 8.0% |
|
GENE-43. Targeting GABPb1L Inhibits In Vivo Growth of TERT Promoter Mutant Glioblastoma
Neuro-Oncology 21 (Suppl 6), vi106, 2019 View on Google Scholar ↗ |
2019 | 1 | 7.2% |
|
Site-specific generation of protein-protein conjugates using native amino acids
2019 View on Google Scholar ↗ |
2019 | 1 | 7.2% |
|
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
US Patent App. 16/898,161, 2020 View on Google Scholar ↗ |
2020 | 1 | 7.1% |
|
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity (vol 15, pg 891, 2020)
Nature Biotechnology 38 (7), 901-901, 2020 View on Google Scholar ↗ |
2020 | 1 | 7.1% |
|
Structural coordination between active sites of a Cas6-reverse transcriptase-Cas1—Cas2 CRISPR integrase complex
bioRxiv, 2020.10. 18.344481, 2020 View on Google Scholar ↗ |
2020 | 1 | 7.1% |
|
The Nobel Prize in Chemistry 2020: Celebrating the collaborative efforts leading to a tool (CRISPR-Cas) for rewriting a code of life.
Current Science (00113891) 119 (10), 1603, 2020 View on Google Scholar ↗ |
2020 | 1 | 7.1% |
|
Molecular Biology: Structural Roles for Human Translation Factor eIF3 in Initiation of Protein Synthesis
SCIENCE-NEW YORK THEN WASHINGTON- 5753, 1513, 2005 View on Google Scholar ↗ |
2005 | 1 | 7.0% |
|
Protein-nucleic acid interactions: unlocking mysteries old and new
Current opinion in structural biology 15 (1), 65, 2005 View on Google Scholar ↗ |
2005 | 1 | 7.0% |
|
Structural Characterization and Identification of Post‐Translational Modifications of Human Eukaryotic Initiation Factor 3 (eIF3) by FTICR Mass Spectrometry
The FASEB Journal 20 (4), A528-A528, 2006 View on Google Scholar ↗ |
2006 | 1 | 6.9% |
|
Spotlight: A Conversation with Laura Kiessling and Jennifer Doudna
ACS Chemical Biology 13 (2), 290-295, 2018 View on Google Scholar ↗ |
2018 | 1 | 6.8% |
|
Candidate Phyla Radiation Roizmanbacteria from hot springs have novel, unexpectedly abundant, and potentially alternatively functioning CRISPR-Cas systems
bioRxiv, 448639, 2018 View on Google Scholar ↗ |
2018 | 1 | 6.8% |
|
Correction: Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
PLoS Biology 16 (4), e1002628, 2018 View on Google Scholar ↗ |
2018 | 1 | 6.8% |
|
RNA: primed for packing?
Chemistry & biology 11 (2), 149-151, 2004 View on Google Scholar ↗ |
2004 | 1 | 6.7% |
|
Conformational Dynamics of Cas9 during DNA Binding
Biophysical Journal 112 (3), 71a, 2017 View on Google Scholar ↗ |
2017 | 1 | 6.6% |
|
CRISPR book review—Doudna responds
Nature 547 (7662), 162-162, 2017 View on Google Scholar ↗ |
2017 | 1 | 6.6% |
|
Endoribonuclease compositions and methods of use thereof
US Patent 9,708,646, 2017 View on Google Scholar ↗ |
2017 | 1 | 6.6% |
|
Mutant proteinase with reduced self-cleavage activity and method of purification
US Patent App. 13/898,650, 2013 View on Google Scholar ↗ |
2013 | 1 | 6.6% |
|
Mutant Proteinase with Reduced Self-Cleavage Activity and Method of Purification
US Patent App. 14/567,368, 2015 View on Google Scholar ↗ |
2015 | 1 | 6.3% |
|
Tailoring the Genome
Trends in cancer 2, 536-7, 2016 View on Google Scholar ↗ |
2016 | 1 | 6.3% |
|
Method of producing dicer
US Patent 8,852,911, 2014 View on Google Scholar ↗ |
2014 | 1 | 6.3% |
|
Identifying RNA contacts from SHAPE-MaP by partial correlation analysis
arXiv preprint arXiv:1412.3800, 2014 View on Google Scholar ↗ |
2014 | 1 | 6.3% |
|
The dicer-TRBP Interface structure and implications for Strand selection during Microrna biogenesis
Biophysical Journal 106 (2), 463a, 2014 View on Google Scholar ↗ |
2014 | 1 | 6.3% |